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Aquaculture Research  between February 2014 and June 2015 as part of the research project
Optiﬁber (KPN-NFR 224819/E40).
This thesis is structured as follows. The introduction describes, along general lines, colon
cancer and dietary ﬁbers as the background of the study. Also the theory of real-time quantitative
RT-PCR (RT-qPCR) is described there. The introduction is meant to support readers unfamiliar
with RT-qPCR in understanding the following parts of the thesis. The adapted RT-qPCR method,
which is necessary for establishing a test system for analyzing the mechanisms behind the potential
protective eﬀects of the dietary ﬁbers, is described in the methods. The adaption of the RT-qPCR
method was the main aim of the thesis. The application of the test system to one speciﬁc dietary
ﬁber is detailed in the results. The strengths and weaknesses of the test system are then discussed
together with the results of the application. The thesis ends with a conclusion and suggestions for
future studies.
This thesis was typeset using LATEX including the ChemFig package for chemical structures.
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IV Summary
A higher intake of dietary ﬁbers is associated with a decreased risk of colorectal cancer. The molec-
ular mechanisms of the protective eﬀect of dietary ﬁbers against colorectal cancer are, however,
still largely unknown.
In this thesis, a simple screening test system was established for studying the molecular mech-
anisms behind the potential protective eﬀects of the dietary ﬁber type β-glucan which is the main
component of the product dispersible wellmune and the ﬁber metabolite butyrate. In the test
system the, changes in gene expression of NFκB1, PTGS2, and NFE2L2 induced by dispersible
wellmune or butyrate treatment in the human colon carcinoma cell lines HT-29 and HCT-116 were
investigated. For establishing the test system, a quantitative real-time reverse transcription PCR
(RT-qPCR) method was adapted which included the development of an optimized RNA isolation,
cDNA synthesis, PCR method, and reference gene selection for data normalization. The stability
of the four reference genes GAPDH, 18S rRNA, B2M, and ACTB after treatment with dispersible
wellmune or butyrate was analyzed. Data analysis using ANOVA combined with a Tukey HSD test
and the stability validation programs BestKeeper and NormFinder indicated that 18S rRNA, B2M,
and ACTB were the most stable reference genes while GAPDH was stated as unstable and not
suitable for normalization. Further evaluations conﬁrmed that GAPDH was indeed not suitable
for data normalization in HT-29 cells. However, this was not the case in HCT-116 cells.
By using the adapted RT-qPCR method it was shown that a treatment with dispersible well-
mune or butyrate led to a down-regulation in gene expression of NFκB1 and PTGS2 and an
up-regulation of NFE2L2 in HT-29 cells after 24 hours treatment time. The best treatment time
was 24 hours, all gene expression alterations were observable after this time period which was not
the case after three and six hours treatment time. The only exception was the down regulation
of NFE2L2 after six hours with butyrate treatment, which was no longer visible after 24 hours of
treatment. The gene expression alterations observed in HCT-116 cells after 6 hours of incubation
with dispersible wellmune or butyrate followed the same trend as observed for HT-29 cells. The
HCT-116 cell line does not express the PTGS2 gene.
For establishing the screening test system and utilizing the RT-qPCR method, the experimental
setup with the above mentioned steps needed to be rigorously controlled. The observed alterations
in the gene expression of the target genes when using the RT-qPCR method may be one potential
mechanism of how dietary ﬁbers protect against the development of colon cancer.
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1 Introduction
1.1 Background: Colon cancer and dietary ﬁber
1.1.1 Brief overview
In 2014, colorectal cancer was the fourth most common type of cancer in the world (Stewart and
Wild, 2014). According to Slattery et al. (1998), the Western-style diet characterized by a high
proportion of red or processed meat and reﬁned grains, is associated with an increased risk of
colorectal cancer, while a increased consumption of whole grains and vegetables will reduce the
risk of colorectal cancer. Already Burkitt (1969) found that the intake of dietary ﬁbers is inversely
associated with the risk of developing colorectal cancer. Becker et al. (2004) have evaluated the link
between dietary ﬁber intake and decreased risk of colon cancer development as moderately likely.
Even though many studies have shown a protective eﬀect of dietary ﬁber, there are still controversy
results. These diﬀerences may be due to the use of diﬀerent ﬁber sources. Dietary ﬁbers are a
heterogeneous group of carbohydrate polymers with diﬀerent structures. Consequently, diﬀerent
dietary ﬁbers may have diﬀerent protective eﬀects. However, the molecular mechanisms behind
dietary ﬁbers potential protective eﬀect on colon cancer development are still poorly understood.
The aim of this thesis was therefore to create a test system that can be used to screen diﬀerent
dietary ﬁbers for their eﬀects and at the same time increase the understanding of the molecular
mechanism that form the basis of the protective eﬀect of dietary ﬁbers in colon cancer development.
1.1.2 Function of the gut
The human gut, also known as gastrointestinal tract, is an approximately eight meter long tube
which digests food, absorbs nutrients and expels waste. The gut stretches from the mouth to the
anus (Williams, 2012, p.133). The gut can be divided into several parts, comprising the stomach,
small intestine, large intestine (also called the colon) and rectum, which is illustrated in Figure 1.
In humans, the main digestion process is carried out in mouth, stomach, and small intestine.
During this process, nutrients are made available for uptake. Nutrients are mainly taken up in the
small intestine. In the large intestine, the microbiota ferment indigestible parts of the food such
as dietary ﬁbers. Simultaneously, water and salts are extracted and absorbed.
The intestine is divided into the small intestine and the colon also called the large intestine.
The colon can further be divided into the distal and the proximal colon (Figure 1).
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Figure 1: Sections of the human gastrointestinal tract (adapted from von der Burchard (2012)
(24.4.2015)).
1.1.3 Colon cancer
One deﬁnition of cancer is that cells in the body divide without control and spread into the
surrounding tissue. When the cells are dividing and an abnormal mass of tissue is formed this
mass is called a tumor. Tumors can be malignant or benign. Benign tumors lack the ability to
invade other tissues in the body. When benign tumors are left untreated they have the potential
to become malignant. Malignant tumors can innvade the surrounding tissue and can spread into
tissues further away. The process when a tumor is developing from a benign to a malignant form
is accompanied by angiogenesis. In angiogensis, the formation and maturation of blood vessels
occurs in order to provide the needed oxygen and nutrients to the growing tumor.
Cancer that occurs in the appendix, colon, or rectum is called colorectal cancer. The speciﬁc
colorectal cancer types share many characteristics and are therefore often studied as a group.
According to Stewart and Wild (2014), colorectal cancer was the fourth most frequent cancer type
after lung, liver, and stomach cancer world-wide in 2014. Norway was one of the countries with the
relatively highest occurrence of colorectal cancer in the time period 2009 to 2013 (Larsen, 2013). In
a preliminary phase of colorectal cancer, normal colonic epithelium cells start dividing and forming
benign polyps. In 80% of the cases these polyps are formed due to a mutation in the adenomatous
polypois coli (APC ) gene (Rowan et al., 2000). APC is a tumor suppressor gene that prevents
the cell from uncontrolled growth. Polyps can progress into malignant growing carcinoma. This
step is often accompanied by an alteration in the tumor suppressor gene TP53 which encodes the
protein p53. This protein plays an important role in inhibition of angiogenesis and apoptosis (the
process of programmed cell death) and a mutation in the gene may result in the resistance of the
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cell to apoptosis.
Colorectal cancer development is driven by the loss of genomic stability. This can either be
chromosomal or microsatellite instability. When chromosomal instability occurs the chromosomal
copy number and structure will be changed and the wild-type copy number of genes such as APC
and TP53 can get lost (Markowitz and Bertagnolli, 2009). In microsatellite instability, alterations
in the length of microsatellite sequences will occur due to an inactivated DNA mismatch repair
system. Mutations in coding sequences result in frameshift mutations and these can cause the
production of truncated or functionally inactive proteins (Kim et al., 2013).
The development of cancer is frequently due to genetic mutations but these mutations are often
not suﬃcient. Chronic inﬂammation is also associated with the development of cancer (Balkwill
and Mantovani, 2001; Coussens and Werb, 2002). Chronic intestinal inﬂammation can cause in-
ﬂammatory bowel disease. A direct link between chronic diseases and the development of cancer
was observed among patients with inﬂammatory bowel disease. These patients had an increased
risk of developing colorectal cancer (Zhang and Hamaker, 2010). In the cancer development, the
inﬂammation level is high and there is an ongoing vascular remodeling and proliferation of tu-
mor vessels (Nelson and Ganss, 2006). Furthermore, the tumor needs enzymes such as matrix
metalloproteinases for growing and invading new tissue (Mook et al., 2004). Also the enzyme
prostagladin-endoperoxide synthase 2, which is encoded by the gene PTGS2, is associated with
the control of cell growth is over-expressed in colorectal tumor tissue (Eberhart et al., 1994).
1.1.4 Dietary ﬁbers
Dietary ﬁbers are a heterogeneous group of carbohydrate polymers. According to the CODEX
Alimentarius Commission, dietary ﬁbers are deﬁned as carbohydrate polymers with ten or more
monomeric units, which are not hydrolyzed by endogenous enzymes in the small intestine of hu-
mans. Dietary ﬁbers can be naturally occurring in food as consumed, obtained from raw material
or be synthetic carbohydrate polymers. Fibers obtained from raw material or synthetic carbohy-
drate polymers must show a proven physiological beneﬁt in human health in order to be oﬃcially
accepted as dietary ﬁbers (World Cancer Reserach Fund / American Institute for Cancer Research,
2007).
Dietary ﬁbers can be classiﬁed as either resistant starch (starch that resists digestion), non-
starch polysaccharides, or lignin. Cellulose, pectin, arabinoxylan, and β-glucans belong amongst
others to the group of non-starch polysaccharides. Dietary ﬁbers can be soluble or insoluble in
water. Soluble ﬁbers, such as pectin, cereal β-glucan, and some arabinoxylans are fermented in
the proximal colon. They can absorb water, form viscous solutions, and slow down the digestion.
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Soluble ﬁbers have the potential to lower blood cholesterol levels and regulate the blood glucose
postprandial rise (Brennan and Cleary, 2005). Sources of soluble ﬁbers can be oat, barley, carrots,
and apples. Insoluble ﬁbers, namely cellulose, lignin, some arabinoxylans, and β-glucans from
yeast pass relatively intact through the gastrointestinal tract. They are fermented more slowly in
the distal colon, rectum and faeces than soluble ﬁbers, and they have a laxative eﬀect and increase
the faecal bulk (McIntyre et al., 1991). Whole wheat ﬂour, nuts, green beans, and potatoes are
good sources of insoluble ﬁbers. Most foods contain both soluble and insoluble ﬁber.
1.1.5 Dietary ﬁbers and colon cancer
General Development of colorectal cancer and diet are directly linked: it is estimated that 70% of
all cases of colorectal cancer are provoked by dietary factors (Young et al., 2005). The consumption
of red meat, fat, alcohol, and lifestyle issues such as smoking and obesity are associated with
colorectal cancer (Qasim and O'Morain, 2010). Burkitt (1977) hypothesized that an increased
intake of dietary ﬁbers may reduce the occurrence of colon cancer. This hypothesis was based on
observations of lower colon cancer rates in East Africa compared to more industrialized countries.
The ﬁber-rich diet comprising unreﬁned grains and vegetables in Africa can be a reason for this
observation. Burkitt (1969) assumed that dietary ﬁbers can protect against colon cancer. This was
not conﬁrmed in later studies. The case control studies of Freudenheim et al. (1990) and Howe et al.
(1992) support the assumption of Burkitt (1969) and showed a strong to moderate protective eﬀect
of dietary ﬁbers against colon cancer. Both studies conclude that reducing the risk of developing
cancer by 50% requires the consumption of approximately 30 g ﬁbers every day. The source of
ﬁber was not deﬁned in these studies. In epidemiological studies, the protective eﬀect of dietary
ﬁber was not as strong as in the case control studies and only weak protective eﬀects of dietary
ﬁber could be veriﬁed (Kim, 2000). The diﬀerent outcomes of the studies may be due to diﬀerent
ﬁber sources used. Fibers from diﬀerent sources can diﬀer profoundly in their structures as dietary
ﬁbers are a heterogeneous group comprising carbohydrates polymers with various structures that
most likely these will have diﬀerent eﬀects (Aune et al., 2011). For determining which type of ﬁbers
have the greatest beneﬁcial potential and for understanding their protective eﬀects, the molecular
mechanisms need to be studied.
Potential mechanisms behind the protective eﬀect The mechanism behind the protective
eﬀect of dietary ﬁbers against colorectal cancer is not fully evaluated. However, faecal bulking and
bacterial fermentation are two of the most likely possible mechanisms.
Dietary ﬁbers can bind water which increases the faecal bulk. This leads to a dilution of
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carcinogens (Harris and Ferguson, 1993). Faecal bulking is also associated with a reduced transit
time and a shorter time period in which epithelium cells in the colon and rectum are exposed to
carcinogenic compounds (Ferguson et al., 2000).
The adult colon is the habitat of approximately 1014 bacteria from over 1000 diﬀerent species
(Zhang and Hamaker, 2010). These bacteria are the most abundant group of microorganisms that
form the gut microbiota. The host organism and the microbiota form a mutualistic relationship.
During the colonic fermentation of dietary ﬁbers, the microbiota utilize food components that were
not digested in the small intestine. This process serves as an energy source for the microbiota.
Dietary ﬁbers undergo fermentation. Short chain fatty acids (SCFA) are the most important
metabolites that are formed during fermentation of dietary ﬁbers. SCFA are energy substrates for
the colonocytes (colonic epithelial cells), play a key role in colon health (Canani et al., 2011), and
have anti-inﬂammatory properties (Jacobasch et al., 1999). Due to the heterogeneity of dietary
ﬁbers, diﬀerent microorganisms will have the ability to utilize diﬀerent types of dietary ﬁber. The
source of dietary ﬁbers will therefore drive a selection towards the microorganisms with best ability
to digest the typical type of ﬁbers consumed and the amount of these microorganisms will increase.
Changes in the ﬁber composition leads to alterations in the microbiota and the composition of
SCFA.
Butyrate Beside acetate and propionate, butyrate is the main SCFA produced in dietary ﬁber
fermentation. Besides its eﬀect as epithelium energy source, it also induces apoptosis when added
to carcinoma cell lines in vitro (Hinnebusch et al., 2002). At the same time, butyrate acts as an anti-
inﬂammatory agent through the inhibition of the activation of the inﬂammation associated nuclear
factor kappa B (NF-κB) (Segain et al., 2000). Furthermore is the over-expression of the enzyme
prostaglandin H2 synthase 2 (PTGS2) in colon tumor tissue suppressed by butyrate (Tong et al.,
2004). The inhibition may be due to butyrate's ability to inhibit the enzyme histone deacetylases.
Beta-glucans A heterogeneous group of dietary ﬁbers are β-glucans, consisting of β-linked glu-
cose monomers. They are structural components of the cell wall in fungi, yeast, some bacteria,
and certain grains. Their structure diﬀers depending on the source. Cereal β-glucans, for example,
are linear molecules consisting of mixed linked β-(1,4)-β-(1,3) glucose monomers (Figure 2). They
are primarily found in barley and oat and are largely soluble in water. Yeast β-glucans on the
other hand, are branched molecules consisting of a backbone of β-(1,3)-linked glucose monomers
with β-(1,6)-linked side chains (Figure 3). Most yeast β-glucans are insoluble in water. Cereal and
yeast β-glucan have been ascribed immune-modulating properties and several studies have reported
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anti-tumor or immune-modulating eﬀects (Ross et al., 1999; Lee et al., 2001; Davis et al., 2004; Qi
et al., 2011; Stier et al., 2014). Oral administration of yeast and barley β-glucans has, for example,
been shown to increase the eﬃcacy of anti-tumor monoclonal antibodies in a mouse tumor model
(Hong et al., 2004). The eﬀect could be related to the carbohydrate structure (Hong et al., 2004).
Yeast β-glucans are often found to have a more pronounced eﬀect than cereal β-glucans. The
direct structure-dependent immune-modulating potential of certain dietary ﬁbers is increasingly
recognized (Wismar et al., 2010). In this thesis, a particulate yeast β-glucan preparation of high
purity denoted dispersible wellmune was therefore chosen as a representative of this group of ﬁbers
with a potential immune-modulating eﬀect.
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Figure 3: Structure of yeast β-glucan. Figure adapted from Volman et al. (2008)
1.2 Background: Quantitative real-time reverse transcription PCR
1.2.1 Gene expression
For getting a better understanding of the molecular eﬀects of dietary ﬁbers, the expression of
speciﬁc genes can be studied. In gene expression, the nucleotide sequence of a gene is used for
synthesis of a functional gene product. Quantitative real-time reverse transcription PCR (RT-
qPCR) became an extensively applied technique for quantitative analysis of gene expression.
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1.2.2 General introduction to RT-qPCR
Since its invention by Mullis in 1983 (Mullis et al., 1990), the polymerase chain reaction (PCR)
became a laboratory technique of greatest impact in biological research. With PCR it became
possible to amplify speciﬁc regions of DNA sequences. PCR is a common molecular biological
application and is often used in gene expression analysis, DNA cloning, and DNA sequencing.
For determining whether the target DNA sequence was ampliﬁed or not, downstream processing
like gel electrophoresis is needed. In order to improve the PCR, Higuchi et al. (1992) omitted
the downstream processing by adding ethidium bromide to the PCR. Ethidium bromide binds to
double-stranded DNA and its ﬂuorescence increases with the increasing amount of ampliﬁed DNA
enabling real time monitoring of the PCR.
Higuchi et al. (1992) accomplished the ﬁrst demonstration of real-time PCR (qPCR). The
qPCR refers to PCR ampliﬁed DNA that can be monitored and measured after each PCR cycle.
In qPCR, ﬂuorogenic probes are used that make it possible to detect a ﬂuorescence signal after
each PCR cycle.
RNA cannot be ampliﬁed in PCR and a DNA template is needed. RNA can be converted into
DNA by reverse transcription. Reverse transcription is originally a process used by retroviruses
where the enzyme reverse transcriptase synthesizes complementary DNA (cDNA) in the host cell
from virus RNA. In this way, retroviruses incorporate their genetic material into the host genome.
Since the ﬁrst description of the reverse transcriptase by Howard and Satoshi (1970) and Baltimore
(1970) the method is used in molecular biological processes such as creating cDNA libraries and
PCR based applications. A reverse transcription reaction followed by PCR is called reverse tran-
scription PCR (RT-PCR). When qPCR and RT-PCR are combined, this process is called real-time
RT-PCR (RT-qPCR). RT-qPCR comprises of the following steps: (i) RNA isolation, (ii) cDNA
synthesis, and (iii) PCR.
1.2.3 Diﬀerent steps in RT-qPCR
cDNA synthesis By combining the reverse transcription reaction with the PCR it becomes
possible to study RNA transcripts with a low copy number of starting material (Dorak, 2006, p.4).
In RT-PCR and RT-qPCR single-stranded cDNA templates are synthesized for later PCR. This
is called ﬁrst-strand cDNA synthesis. In the ﬁrst-strand cDNA synthesis in RT-qPCR, a single
stranded DNA primer is hybridized to a single stranded RNA template. Reverse transcriptase
then binds to the primer:RNA template complex and starts the reverse transcription. The reverse
transcriptase has three diﬀerent activities: (i) RNA-dependent DNA polymerase, (ii) ribonucle-
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ase H, and (iii) DNA-dependent DNA polymerase activity. For the cDNA synthesis in RT-qPCR,
activity (i) and (ii) are utilized. Today, the two most commonly used reverse transcriptases for
cDNA synthesis are the reverse transcriptases of the Avian myeloblastosis virus (AMW) and the
Moloney murine leukemia virus (MMLV) (Okello et al., 2010). When the reverse transcriptase is
bound to the primer:RNA template complex, it starts the DNA synthesis from the 3' end of the
DNA primer and adds free nucleotides to the 3' end of the new formed strand. The RNA strand
serves as template for this reaction. A DNA:RNA hybrid is formed. The RNase H activity of the
reverse transcriptase may lead to the degradation of RNA in the DNA:RNA hybrid. However both
DNA:RNA hybrid and single stranded DNA can be used as staring material for the following PCR
as the initial denaturating step will break up all double-stranded DNA:RNA hybrids.
The right choice of primer in cDNA synthesis is essential for the eﬃciency of this step. There
are three diﬀerent types of primers that can be used for cDNA synthesis: (i) sequence speciﬁc,
(ii) oligo(dT), and (iii) random hexamer primers.
Sequence speciﬁc primers bind only to a speciﬁc sequence on the mRNA. These primers oﬀer
high speciﬁcity. At the same time they are not very ﬂexible since a new cDNA synthesis has to be
performed for each gene included in the study.
Oligo(dT) primers are more ﬂexible than sequence speciﬁc primers since they do not bind to
a speciﬁc sequence but more generally to the poly(A) tails of messenger RNA (mRNA) molecules
(Figure 4A). This allows the study of several genes in the ensuing PCR ampliﬁcation. A disadvan-
tage using oligo(dT) primers is that they are biased towards the 3' end of the transcript. Because
the reverse transcriptase enzyme sometimes falls oﬀ and the 5' end is missing, it can be diﬃcult to
produce full length cDNA (Dorak, 2006, p.4).
Random hexamer primers are six nucleotides long. The shortness of these type of primers open
for many possible binding sites in the target. They are therefore thought to bind randomly to
any site of the target RNA template (Figure 4B). In contrast to oligo(dT) primers, they can bind
also to non-polyadenylated RNA. Random hexamer primers have the disadvantage to be biased
towards the 5' end of the target (Dorak, 2006, p.4). Since all RNA is
In summary, each primer type has advantages and disadvantages. Before starting a new RT-
qPCR experiment the primer choice should be evaluated towards the primer with best sensitivity
and accuracy in the cDNA synthesis.
PCR In a PCR, a DNA template is copied. Each PCR cycle consists of three steps: (i) de-
naturation, (ii) annealing, and (iii) elongation. In the denaturation step, double-stranded DNA or
cDNA:RNA hybrid templates are denaturated at approximately 95 ◦C. The annealing step is ini-
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Figure 4: The use of oligo(dT) and random hexamer primers in cDNA synthesis. The reverse
transcriptase of MMLV binds to the speciﬁc primer. With its RNA dependent DNA polymerase
activity (RdD), the polymerase generates cDNA from the RNA template. After cDNA synthesis,
the RNA can be degraded by the ribonuclease H (H) activity of the reverse transcriptase. A:
The primer oligo(dT) (o(dT)) anneals to the poly A tail of the mRNA strand. B: Two binding
possibilities of the random hexamer (R H primer) primer annealing to the RNA strand.
tiated by lowering the temperature to approximately 55 ◦C such that primer and probe can anneal
to the single-stranded DNA. The annealing temperature depends on the primer sequence. In the
elongation step, the temperature is increased to 72 ◦C which is the optimal temperature for DNA
polymerase activity. DNA polymerase extends the primers by adding complementary nucleotides
to the DNA template. This process is repeated 25 to 40 times (McPherson and Møller, 2006).
DNA polymerases used in PCR need to be heat resistant. The two most commonly used
DNA polymerases are Pfu and Taq DNA polymerases (Valasek and Repa, 2005). Taq polymerase
is the DNA polymerase of the thermophilic gram-negative bacterium Thermus aquaticus. Taq
polymerase has two catalytic activities, one domain for synthesizing a new DNA strand and a
5'-nuclease domain for cleaving DNA bound downstream of the DNA synthesis.
Real-time PCR uses the same mechanisms as conventional PCR, with the addition of a ﬂuores-
cent agent which enables the monitoring of DNA sequence ampliﬁcation in real-time. Two major
principles can be distinguished: (i) ﬂuorescent dyes that bind to double-stranded DNA and (ii)
dye-labeled sequence speciﬁc probes, that bind to single-stranded DNA. Only the latter will be
further described.
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Figure 5: The FRET mechanism. In this example the green dye is the reporter dye and the
red dye is the quencher dye. A: The green and the red dye are bound to the same probe. After
excitation of the green dye, FRET occurs and the emission energy is transferred from the green
dye to the red dye. B: FRET cannot occur because of the large distance between green and red
dye. The green dye emits its signal. (Adapted from: Life Technologies (2012))
1.2.4 TaqMan  a representative of dye-labeled sequence speciﬁc probes
Dye-labeled sequence speciﬁc probe chemistry like TaqMan (Thermo Fisher Scientiﬁc, Waltham,
Massachusetts, USA) utilizes the ﬂuorescence resonance energy transfer (FRET) mechanism. In
this mechanism the emission of one ﬂuorescent dye is reduced by the close proximity of another
dye bound to the same probe. The mechanism of FRET is exempliﬁed in Figure 5A. The green
dye is excited by light. When the green and the red dye are close to each other, FRET will occur.
Instead of emitting the light to return from the electronic excited state to ground state, the green
dye transfers the energy directly to the red dye. In other words, the red dye quenches the green
dye. Since the eﬃciency of the energy transfer is highly dependent on distance, FRET is negligible
when the two dyes are not in close proximity. In this case, the green dye returns to the ground
state by emitting light (Figure 5B) (Life Technologies, 2012).
As mentioned above, TaqMan assays consist of sequence-speciﬁc probes and two sequence-
speciﬁc primers. The probe is ﬂuorescently labeled by a quencher at the 3' end and a reporter at
the 5' end of the probe. FRET occurs when reporter and quencher are in close proximity. Diﬀerent
reporter and quencher dyes can be chosen. Here only the TAMRA quencher and the MGB probe
will be mentioned.
TAMRA is a quencher used since a long time. It is a ﬂuorescent molecule in itself and gives
therefore a weak background signal (Life Technologies, 2012). TAMRA probes tend to be long
because the melting temperature of the probes have to be higher than the melting temperature
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Figure 6: Use of TaqMan chemistry in PCR. A: The TaqMan probe consists of a reporter (R)
and a non-ﬂuorescent quencher (NF) bound to a minor groove binding (MGB) molecule. Taq DNA
polymerase (Taq) consists of a synthesis domain (Syn dom) and a 5' nuclease domain (ND). Taq
DNA polymerase synthesizes DNA in 5' - 3' direction (indicated by a blue arrow). B: During
PCR, Taq displaces the probe and cleaves the reporter. FRET does not occur any longer and the
reporter ﬂuoresces.
of the primers. This way, it is ensured that the probes bind strongly enough before the primers
anneal and the DNA synthesis starts. But long probes can give lower speciﬁcity. To overcome this
problem it can be advisable to use shorter probes, like MGB probes (Figure 6) (Life Technologies,
2012).
At the 5' end of the MGB probes, a reporter dye is bound while at 3' end of the MGB probes
two subunits are bound: (i) a non- ﬂuorescent dye (NFG) and (ii) a minor groove binding (MGB)
molecule which is attached to NFG. NFG gives no background ﬂuorescence. A minor groove is
formed when the probes bind to the target sequence. MGB can bind to this groove and strengthen
the probe:target sequence binding. In this case, it is possible to generate shorter probes (Life
Technologies, 2012).
Before a thermostable DNA polymerase, such as Taq polymerase starts DNA synthesis, only
small amounts of quenched reporter dye can be measured, this is independent of the chosen
quencher dye (Figure 6A). Taq polymerase has two domains, the synthesis domain, responsible
for the DNA synthesis and the 5' nuclease domain responsible for degradation of downstream
DNA. Taq polymerase synthesizes DNA in 5' - 3' direction. When it reaches the probe at its
5' end, the reporter is cleaved oﬀ by the 5'  3' exonuclease activity of the polymerase. Reporter
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Figure 7: Schematic graph of a single ampliﬁcation plot in RT-qPCR. CT denotes the threshold
cycle and ∆Rn the ﬂuorescence signal of the ampliﬁcation product subtracted from the ﬂuorescence
signal of the baseline (adapted from Arya et al. (2005)).
and quencher are permanently separated, consequently FRET cannot occur any longer, and the
reporter dye ﬂuoresces. The resulting ﬂuorescence signal is proportional to the amount of ampliﬁed
sample. Taq polymerase continues the DNA synthesis.
The application ﬂuorescent probes like TaqMan result in an increase in ﬂorescence by a suc-
cessful ampliﬁcation. These ﬂuorescence signals can be detected and visualized by ampliﬁcation
plots as illustrated in Figure 7.
∆Rn is the baseline corrected ﬂuorescent signal and is calculated by
∆Rn = Rnf −Rnb, (1)
where Rnf is the amount of ﬂuorescence signal of the PCR product at each cycle and Rnb is the
amount of ﬂuorescence signal at the baseline.
The baseline of RT-qPCR is deﬁned as the initial PCR cycles where only little changes in the
ﬂuorescence signal occur (Dorak, 2006, p.xix). This level of ﬂuorescence is the background of the
reaction.
The threshold is the level where the ﬂuorescent signal of the RT-qPCR increases signiﬁcantly.
The threshold distinguishes the background from the relevant ampliﬁcation. It is calculated as ten
times the standard deviation of the baseline ﬂuorescent signal (Arya et al., 2005).
The threshold cycle (CT ) is deﬁned as the number of PCR cycles needed for the ﬂuorescent
signal to cross the threshold (Walker, 2002). The CT is inversely related to the starting amount of
template in the reaction. Increasing the amount of template DNA in the beginning of the reaction
leads to smaller CT values. When the reaction components become limited, the ampliﬁcation rate
will decrease. This phase is called the plateau phase.
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The CT values can reach a threshold after which the detection of the gene expression is consid-
ered as unreliable. For the TaqMan assay this threshold is for example everything above 35 cycles.
A CT value above this may correspond to a gene which is not or only expressed in a small amounts
(Life Technologies, 2010).
1.2.5 Absolute and relative quantiﬁcation
Absolute quantiﬁcation RT-qPCR can quantify gene expression by absolute or relative quan-
tiﬁcation. The absolute quantiﬁcation is used when the expression level of absolute numbers needs
to be determined such as the number of viral particles per ml of blood (Bio-Rad Laboratories,
2006). The quantity of a target gene is estimated from a range of standards with known concen-
trations. The standard with known quantity is serially diluted and a standard curve is generated
by plotting the log quantity against the CT values. By interpolation, the quantity of the unknown
target can be measured (Bio-Rad Laboratories, 2006). For absolute quantiﬁcation it is essential to
have stable and reliable standards with known amounts of target genes.
Relative quantiﬁcation One way to quantify relative changes in target gene expression is by
setting the change in relation to at least one reference. Using reference genes is the most common
method for normalization of gene expression (Bustin et al., 2009).
In normalization, diﬀerent amounts of RNA starting material, and variations in reverse tran-
scription yield can be controlled. Since RT-qPCR comprises further on a lot of processing and
extraction steps, a proper normalization step is of high importance to get sensitive and reliable
results.
The suitability of the reference genes has to be validated for a particular cell type or tissue
(Bustin et al., 2009). A good reference gene should fulﬁll four criteria: it (i) needs a stable expres-
sion in diﬀerent experimental treatments and developmental stages, (ii) has a similar ampliﬁcation
eﬃciency as the target gene, (iii) should be abundantly expressed, and (iv) should be expressed at
the same level as the target gene (Ling et al., 2014). Programs such as NormFinder, BestKeeper
or geNorm can be used to select the most stable reference genes after an ampliﬁcation reaction.
All these programs are based on diﬀerent algorithms and this can result in diﬀerent suitabilities
of the reference genes (Anstaett et al., 2010). It is also advisable to use more than one stable
reference gene for normalization. According to Bustin et al. (2009), the use of a single reference
gene for normalization is not acceptable unless clear evidences for the use of single reference genes
exist (e.g. previously tested and validated reference genes for equal experiments and conditions).
Vandesompele et al. (2002) showed that the use of single reference genes lead to erroneous nor-
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malization in 25% of their tested samples. Ideally, reference gene selection should be performed by
testing the stability of reference genes after three independent measurements (biological parallels)
with three technical parallels each, using three diﬀerent validation programs. This is also known
as the rule of Best 3 (Kozera and Rapacz, 2013).
Reference genes One of the most commonly used reference genes for the normalization process
is glyceraldedyde 3-phosphate dehydrogenase (GAPDH ). For a long time it was assumed that
GAPDH is only involved in glycolysis. However, in the early 2000s it was found that GAPDH is,
among others, involved in both transcriptional and post-transcriptional gene regulation (McKnight,
2003; Bonafe et al., 2005). The opinions diﬀer between researchers if GAPDH is useful as reference
gene or not. While Edwards and Denhardt (1985) and Winer et al. (1999) showed good results
in their studies using GAPDH, Barber et al. (2005) and Bustin (2000) did not recommend it as
reference gene. As Barber et al. (2005) verify in their study, the mRNA expression level for GAPDH
can diﬀer signiﬁcantly between diﬀerent human tissues while the expression level tends to be more
similar within related groups of tissues like duodenum, jejunum, ileum, and colon.
Another commonly used group of genes for normalization are genes encoding ribosomal sub-
units, with 18S rRNA as a well-known representative. As much as 85% to 90% of the total RNA
in a cell constitutes rRNA (Bustin, 2000). As with the use of GAPDH as a reference gene, it is
important to ensure that the expression of 18S rRNA is not aﬀected by the particular experimental
treatment. Bas et al. (2004) analyzed the expression of diﬀerent genes of T-lymphocytes. They
identiﬁed 18S rRNA as a reference gene that is expressed in stable levels at diﬀerent activation
stages. However, Fu et al. (2010) tried to determine genes for normalization in ovarian tissue
and found that 18S rRNA was unsuitable as a reference gene. Furthermore, there are some other
drawbacks that need to be taken into consideration when rRNA is used as a reference gene. In
contrast to mRNA, ribosomal subunits are not polyadenylated. As a result of this, no oligo(dT)
primer can be used in cDNA synthesis. Furthermore, when using rRNA as reference, total RNA
must be used in the RT-qPCR and not puriﬁed mRNA fractions since rRNA is eliminated from
these samples. Finally, rRNA can be expressed in greater levels than the target gene. This is in
conﬂict with the requirements for reference genes mentioned above.
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1.3 Test system description
In the thesis, a test system was established to study the protective eﬀects of dietary ﬁbers and their
metabolites in colon cancer by using RT-qPCR. In the following paragraphs, the components of the
test system besides the potential reference genes GAPDH, 18S rRNA, β2-microglobulin (B2M ),
and beta-actin (ACTB) will be presented.
Cell lines HT-29 and HCT-116 are both human colon carcinoma cell lines. According to the
American Type Culture Collection, the provider of the cell lines, HT-29 cells have a point mutation
in the TP53 gene. In contrast to HT-29 cells, the TP53 gene is of wild type form in HCT-116 cells.
The cell lines serve as two diﬀerent models for colon cancer in the thesis. In order to have more
control over the test system, cell lines were chosen instead of tissue samples. Cell lines provide a
pure population which is not a mixture of diﬀerent cell types as it is the case in tissue samples
(Kaur and Dufour, 2012) and enables reproducible results.
Target genes The target gene NFκB1 encodes the protein nuclear factor kappa-B p105 subunit
(NFκB1). NFκB1 is one of the structurally related proteins in the NF-κB transcription factor
family. The NF-κB transcription factor family regulates the expression of genes involved in immune
and inﬂammatory responses (Karin et al., 2004). At the same time NF-κB also regulates the
expression of genes which are associated with cancer development and progression (Dolcet et al.,
2005). Lind et al. (2001) found that NFκB was up-regulated in human colorectal cancer and they
further suggested that an inhibition of NFκB may be useful in anti-tumor therapy.
The target gene PTGS2 encodes the human enzyme prostaglandin-endoperoxide synthase 2
(PTGS2). PTGS2 is expressed during inﬂammation and produces prostaglandins (Parrett et al.,
1997). Prostaglandins stimulate angiogenesis and inhibit immune surveillance and are therefore
associated in promoting tumorgenesis (Ben-Av et al., 1995). Eberhart et al. (1994) showed that
PTGS2 is over-expressed in colorectal cancer.
The gene NFE2L2 encodes the nuclear factor erythroid 2-related factor 2 (NFE2L2). The
transcription factor NFE2L2 can be activated due to oxidative stress which is an imbalance between
the production of free radicals and reactive metabolites and the detoxiﬁcation of these reactive
metabolites (Reuter et al., 2010). NFE2L2 regulates genes with antioxidant response elements
(ARE) in their promotor. Most of these genes are involved in stress-response mechanism and
protection of cells against carcinogens. An increased expression of ARE regulated genes is linked
to inhibition of the development of cancer (Zhang and Gordon, 2004).
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Treatment types Butyrate is one of the most abundant SCFA produced by bacterial fermenta-
tion in the colon and has a reported anti-carcinogenic eﬀect. Butyrate us innvolved in the regulation
of genes associated with cell proliferation and apoptosis (Gonçalves et al., 2011). In the human
colon, butyrate concentrations vary between 5 mM (Treem et al., 1994) and 24 mM (Cummings
et al., 1987).
Dispersible wellmune is a food supplement product containing 84% reﬁned yeast-derived β-
(1,3)/(1,6)-glucans. Furthermore the product consists of 7% water and 6% fat fraction. Dispersible
wellmune is known to have an immune-modulatory eﬀect. Fuller et al. (2012) showed that dis-
persible wellmune had a tendency to decrease cold and ﬂu symptoms. Talbott et al. (2013) found
an improvement of allergy symptoms for ragweed-allergy suﬀerers after four weeks with dispersible
wellmune treatment.
1.4 Aim of the thesis
The main aim of this thesis was to establish a test system to study the protective eﬀect of dietary
ﬁbers and their metabolites against colon cancer. The test system is supposed to give new insights
into the molecular mechanisms of this protective eﬀect and at the same time enable the selection of
dietary ﬁber types or metabolites with the highest protective potential in future studies. In order
to achieve this, the commonly used RT-qPCR technique was adapted for the use in colon carcinoma
cell lines HT-29 and HCT-116. The yeast-derived β-glucan product dispersible wellmune and the
dietary ﬁber metabolite butyrate were used as model substances to evaluate the test system. The
following speciﬁc aims were deﬁned:
1. Adaption of the RT-qPCR method which included the development of optimally adjusted
RNA isolation, cDNA synthesis, and PCR methods;
2. Examination and selection of stable reference genes for the RT-qPCR method;
3. Selection of an appropriate butyrate concentration;
4. Evaluation of the suitability of the established test system and examination of changes in
target gene expression in human colon carcinoma cell lines due to the exposure to dispersible
wellmune and butyrate.
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2 Material and Methods
2.1 Cell cultures
Theory: Cell cultures Cell cultures are frequently used tools in biological research. They can,
among others be, used in toxicity testing of new drugs or in cancer research to study diﬀerences
between normal and cancer cells, or diﬀerent cancer treatments (Cree, 2011). Cell cultures can be
obtained from tumor cells.
When initial or primary cell cultures are passaged several times, a cell line is produced. The
advantage of using cell lines as a model system in studies, is the ability to provide renewable material
for repeatable studies since subculturing of cell lines results in a quite homogenous populations of
cells. Tumor-derived cell cultures can be passaged many times when the cells are maintained at
appropriate conditions. Growing cells require amino acids, vitamins, metal ions, and an energy
source. While glucose is often the energy source, the other missing substances are typically provided
by cell culture media and serum. The most widely cell culture media today are Eagle's minimum
essential medium (MEM) and its modiﬁcation Dulbecco modiﬁed MEM (DMEM) together with
Roswell Park Memorial Institute (RPMI) medium. Fetal bovine serium (FBS) is frequently used
as serum. To protect cell lines from or to treat cell lines with bacterial infections, antibiotics like
streptomycin and penicillin are often added to the cell culture medium.
In this study the three human colon carcinoma cell lines HT-29, HCT-116, and Caco-2 where
used.
Application: Cells, reagents and general culture conditions The human colon carcinoma
cell lines HT-29 and Caco-2 were a generous gift from Professor Tor Lea, Norwegian University of
Life Sciences. The human colon carcinoma cell-line HCT-116 was a generous gift from Professor
Gunhild Mælandsmo, Oslo University Hospital. All three cell lines were originally obtained from
the American Type Culture Collection (ATCC). HT-29, Caco-2 and HCT-116 cells were cultured in
DMEM (Thermo Fisher Scientiﬁc, Waltham, Massachusetts, USA) supplemented with 10% FBS
(Thermo Fisher Scientiﬁc), 1% non-essential amino acids (NEAA), 100 U ml−1 penicillin, and
100 µg mL−1 streptomycin. All cultivations (subculturing and treatment) were carried out at 37 ◦C
with 5% CO2 in a humidiﬁed atmosphere.
Application: Subculturing of cell lines For subculturing of HT-29, Caco-2 and HCT-116
cells, the culture medium was removed and the cells were washed twice with 5 mL phosphate-
buﬀered saline (PBS) (Thermo Fisher Scientiﬁc). To detach the adherent cells from the cell culture
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ﬂasks (Sigma-Aldrich Co, St. Louis, Missouri, USA), 3 mL trypsin-EDTA (1X) (Thermo Fisher
Scientiﬁc) were added and incubated at 37 ◦C. After the detachment of the cells, the trypsinization
reaction was stopped by adding 8 ml cell culture medium and mixing the solutions properly. An
appropriate amount of cell suspension was added to fresh 37 ◦C preheated cell culture medium and
incubated at 37 ◦C.
HT-29, Caco-2 and HCT-116 cells were subcultured twice a week. To avoid changes in cell line
characteristics, only passages between ﬁve and 25 were used for experiments. Every sixth week
the cells were tested for Mycoplasma infections using the MycoAlert Mycoplasma Detection Kit
(Lonza, Basel, Switzerland).
Application: Cell treatment for MTT assay Each of the three cell lines, HT-29, Caco-2
and HCT-116, were seeded at a concentration of 2.0 · 105. The cell lines were seeded in 96-well
plates with 100 µL cell culture medium and incubated for 24 hours. Only cells with a conﬂuency
between 70% to 90% were selected for experiments. After the ﬁrst 24 hours of incubation, the
medium was changed to fresh culture medium, or medium containing 0.5, 1.0, 2.5, 5.0, 7.5, 10.0,
or 20.0 mM butyrate (Sigma Aldrich,Co, St. Louis, Missouri, USA) and cells were incubated for
further 24 hours. All experiments were repeated at least three times and cell treatments were
performed in triplicates.
Application: Cell treatment for RNA isolation HT-29 and HCT-116 cells were cultured
in 12-well cell culture plates at a concentration of 2.0 · 105 ml−1 and incubated for three, six, or
24 hours. After this period the cells were treated with either fresh cell culture medium or cell
culture medium containing 2.5mM butyrate or 1 mg mL−1 dispersible wellmune (Biothera, Eagan,
Minnesota, USA, Lot.No: 011). For the use in cell cultures, dispersible wellmune was suspended
in Milli Q water and boiled for 30 minutes. Afterward, the cooled suspension was aliquoted in
endotoxin free centrifuge tubes and freeze dried. The freeze dried dispersible wellmune aliquots
were re-suspended in cell culture medium at a concentration of 1 mg mL−1 in all cell experiments.
The cell culturing for all experiments presented in this thesis, took a total of twelve month.
An overview of all replicates for the following gene expression analysis is shown in Table 1.
2.2 MTT assay
Theory There are various assays available for measuring cell viability. Until the 1980s most
assays were based on the capacity of cells to incorporate radioactive substrate (e.g., Storr and Bur-
ton, 1974; Ashkenazi-Ezra and Ashkenazi, 1976) or to release a radioactive marker (e.g., Kromann
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Table 1: Summary of replicates in gene expression analysis.
Cell line
Incubation time
(hours)
Number of
experimental
replicates
Treatment
replicates
Techniqual
paralells in PCR
3 1 2 2
HT-29 6 1 2 2
24 3 2 2-3
HCT116 6 2 2 2
et al., 1980). An alternative for the radioactive based methods was described by Mosmann (1983).
This assay is based on the ability of metabolically active cells to reduce the yellow tetrazolium
salt MTT into purple formazan crystals (Figure 8). The formazan crystals can be dissolved in
organic solvents and the resulting colored solution can be quantiﬁed using a spectrophotometer.
The advantages of this assay are its high degree of accuracy and its ability to rapidly process large
numbers of samples (Gerlier and Thomasset, 1986).
Br−
N
N+
N
CH3
CH3
S
NN
MTT
N
N
N
CH3
CH3
S
NHN
Formazan
Figure 8: Principle of MTT assay. In the reaction the yellow MTT salt is reduced to purple
formazan crystals.
Application In this thesis, the MTT assay was used to determine a butyrate concentration which
was high enough to cause alterations in the gene expression of the cell line but low enough to avoid
apoptosis. The treated and untreated cells were exposed to 15 µL MTT solution (Roche Applied
Science, Penzberg, Germany). The cells were incubated for 2 hours at 37 ◦C after which the medium
was removed. The formazan crystals were dissolved in 100 µL isopropanol containing 0.04M HCl
and the absorbance was measured at 562 nm using a microplate reader (SPECTROstar nano,
BMG Labtech, Ortenberg, Germany). All experimental treatments were performed in triplicates
and all experiments were performed at least three times.
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2.3 RNA isolation
Theory RNA isolation is the process of extracting RNA from cells. Once extracted, RNA is very
unstable and has only a short half-life due to the ubiquitous presence of RNases. For obtaining
RNA of good quality, which is important for RT-qPCR experiments, RNA isolation relies on
a sterile laboratory technique and RNase-free equipment. Additionally, isolated RNA samples
should not be contaminated with genomic DNA or RNA-isolation reagents like alcohols and phenols
because these can interfere with the RT-qPCR assay. To remove genomic DNA contaminations, a
DNase treatment can be used. RNA concentration and purity can be estimated using an UV-Vis
spectrophotometers such as NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientiﬁc). To
assess the purity of RNA, the NanoDrop spectrophotometer measures the ratio of absorbance at
260 nm and 280 nm. A value of approximately 2.0 indicates a pure RNA sample. A secondary
measure of nucleic acid purity is the ratio of absorbance at 260 nm and 230 nm. For pure RNA
samples, the value should be between 2.0 and 2.2 (Thermo Fisher Scientiﬁc, 2008).
Application Total RNA of HT-29 and HCT-116 cells was extracted using the RNeasy Kit (Qi-
agen, Venlo, Netherlands). The cells were lysed by adding 350 µL of a guanidine-thiocyanate
containing buﬀer. This buﬀer inactivates RNases and is still present when the cells are homog-
enized using QIA shredder spin columns (Qiagen). Ethanol is added to provide suitable binding
conditions for the homogenate to bind to the membrane of the RNeasy Spin Column (Qiagen).
Genomic DNA contaminations were removed using RNase free DNase Kit (Qiagen) according to
the manufacturer's instructions. Other contaminants were washed away in several washing steps
with the buﬀer solutions included in the RNeasy Kit and following the manufacturer's instructions.
RNA was eluted with 30 µL RNase-free water and additionally diluted with 30 µL RNase-free water.
The RNA concentration and purity was measured with a NanoDrop ND-1000 spectrophotometer
(Thermo Fisher Scientiﬁc).
2.4 RT-qPCR
2.4.1 cDNA synthesis
Theory RNA is not stable as template in RT-qPCR. Therefore it has to be converted into cDNA
using an enzyme called reverse transcriptase. At 25 ◦C, a single stranded DNA primer is hybridized
to a single stranded RNA template. Most RNA targets are reverse transcribed into cDNA at 37 ◦C
to 48 ◦C, as this is the optimal temperature range of the reverse transcriptase. At 85 ◦C, the reverse
transcriptase is inactivated, thus preventing it from inhibiting the later PCR. The result of the
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ﬁrst-strand cDNA synthesis is a DNA:RNA hybrid or a single-stranded cDNA.
Application A ﬁxed amount of the isolated RNA samples was used for synthesizing ﬁrst-strand
cDNA with TaqMan Reverse Transcription Reagents (Thermo Fisher Scientiﬁc, Waltham, Mas-
sachusetts, USA). Each RNA sample was uniquely diluted with RNase-free water to reverse tran-
scribe 100 ng RNA into cDNA. Calculations are based on concentrations obtained from NanoDrop
ND-1000 spectrophotometer (Thermo Fisher Scientiﬁc). A mastermix containing all the reaction
components, except the RNA, was prepared to ensure equal quality in all reverse transcription
reactions. Control samples without the reverse transcriptase MultiScribe (a recombinant reverse
transcriptase of MMLV) were included for each set of reactions (NRT samples). The 10 µL samples
contained 1.0 µL RT-buﬀer, 2.2µL MgCl2, 2.0µL deoxy dNTPs, 0.5 µL random hexamers, 0.2µL
RNase inhibitor, 0.25 µL MultiScribe or RNase-free water and 3.85µL appropriately diluted RNA
(to yield 100 ng total RNA). The reverse transcription reaction was performed in a PCR instrument
(GeneAmp PCR system 9700, Thermo Fisher Scientiﬁc) with the following temperature settings:
(i) 25 ◦C for 10 minutes, 48 ◦C for 5 minutes, 95 ◦C for 5 minutes and (ii) a cooling down-step
to 4 ◦C. The cDNA was diluted with 90 µL RNase-free water to a reaction volume of 100 µL and
stored at −20 ◦C until later use. All experiments were performed at least three times.
2.4.2 PCR
Theroy For amplifying the cDNA in PCR, the following temperature steps are recommended
when ﬂuorescent probes are used. The reaction starts with a 10 minutes activation step at 95 ◦C.
This step is followed by a denaturation step at the same temperature for 15 seconds. RNA:DNA
hybrids or newly formed DNA is melted at that temperature and serve as templates for the next
PCR cycle. Annealing and extension are, in contrast to the procedure described on page 8, both
carried out at approximately 60 ◦C. According to Nolan et al. (2006), this temperature is subopti-
mal for the ampliﬁcation by Taq polymerase but at the same time it ensures more eﬃcient cleavage
of the probe.
Application The expression of each gene included in Table 2 was analyzed using the TaqMan
chemistry (Thermo Fisher Scientiﬁc, Waltham, Massachusetts, USA). Each RT-qPCR sample con-
tained 4 µL cDNA, 10 µL TaqMan Gene Expression Master Mix, 1µL TaqMan Gene Expression
Assay (Table 2) and 5 µL RNase-free water. For each RNA isolation (one for each cell culture well),
duplicate (or triplicate) ampliﬁcations of the corresponding cDNA were performed. In addition,
one NRT sample from each RNA isolate was included for each gene to check for genomic DNA
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Table 2: Candidate reference and target genes evaluated in this thesis
Gene symbol Accession number a
Product number TaqMan
gene expression assay
GAPDH NM-001256799.1 Hs02758991_g1
18S rRNA NR-003286.2 Hs99999901_s1
B2M NM-004048.2 Hs00984230_m1
ACTB NM-001101.3 Hs01060665_g1
NF-κB1 NM-001165412.1 Hs00765730_m1
PTGS2 NM-000963.2 Hs00153133_m1
NFE2L2 NM-001145412.2 Hs00975961_g1
aSource: NCBI reference sequence database.
contaminations. The probe was of type FAM/MGB. For each gene (target and reference gene)
non-template controls were included. No ampliﬁcation signals were obtained when RNase-free
water was added instead of cDNA indicating that the reaction mixture was not contaminated by
DNA. The RT-qPCR was performed on an ABI PRISM 7900HT instrument (Applied Biosystems,
Foster City, California, USA) with the following temperature setting: (i) 95 ◦C for 10 minutes, (ii)
40 cycles 95 ◦C for 15 seconds and 60 ◦C for 1 minute. The ampliﬁcation plot and SDS-software
were used to ontain the CT values.
2.5 Data analysis
2.5.1 PCR ampliﬁcation eﬃciency
Theory Constant PCR eﬃciencies in target and reference genes are required in RT-qPCR assays.
Equal PCR eﬃciencies are particularly important when diﬀerences in target gene concentrations
are based on normalization to a reference gene as it is the case for the ΔΔCT method (Bustin
et al., 2009). Diﬀerences in eﬃciencies between target and reference genes can result in over or
under-estimations of expression ratios. The PCR eﬃciency should be as close to 100% as possible.
A 100% eﬃciency means that the cDNA target is doubled in every PCR cycle. The PCR eﬃciency
can be aﬀected by not properly designed primers or probes as well as suboptimal PCR conditions.
The PCR eﬃciency can be determined by
N = N0 · Enc , (2)
where N is the number of ampliﬁed molecules, N0 is the initial number of molecules, E is the
eﬃciency and nc the number of PCR cycles. Equation (2) can be rearranged to
log(N) = log(N0) + nc · log(E), (3)
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nc =
log(N)− log(N0)
log(E)
, (4)
and
nc = − 1
log(E)
· log(N0) + log(N)
log(E)
. (5)
Standard curves can be described by equation (5). The slope of the standard curve is
slope = − 1
log(E)
(6)
and can be used to calculate the eﬃciency
E = 10−slope
−1
. (7)
The eﬃciency of a PCR is optimal if the cDNA target is doubled every PCR cycle. The slope
of the standard curve is -3.32 in the optimal case. The slope is estimated using linear regression
analysis of the CT values explained by the cDNA dilution.
The eﬃciency is given as a percentage value
%E = (E − 1) · 100. (8)
An eﬃciency (%E) of 90% to 110% can be considered as good (Garson et al., 2009).
Application The eﬃciency of the PCR ampliﬁcation of the four candidate reference genes
GAPDH, 18S rRNA, B2M and ACTB was veriﬁed. To do so, a pooled cDNA sample was pre-
pared by taking equal amounts of all treated and untreated cDNA samples from one cell culture
experiment. The PCR eﬃciency was determined by three-point standard curves of a 10-fold dilu-
tion series (1:1 - 1:100). The threshold cycles obtained in the RT-qPCR were plotted against the
concentration of the samples in logarithmic scale. Given an eﬃciency of 100%, the CT will increase
linearly with the decreasing quantity of the target. The eﬃciency was determined by generating a
standard curve and estimating the slope. Each dilution was ampliﬁed in duplicates and an average
was taken.
If not mentioned otherwise, all statistical analysis were carried out in the R software for statis-
tical programing (R Core Team, 2015).
23
2.5.2 Stability of reference genes
Theory The basis for the normalization of target genes is to identify reference genes whose
mRNA expression level does not change signiﬁcantly between diﬀerent treatments. As advised by
Kozera and Rapacz (2013), three diﬀerent validation methods were used to determine the stability
of the reference genes: (i) Analysis of variance (ANOVA) and Tukey honest signiﬁcant diﬀerence
(HSD) test, (ii) BestKeeper software, and (iii) NormFinder software.
By using an ANOVA it can be determined whether mean expression levels given treatments in
a gene diﬀer signiﬁcantly from each other or not. For further comparison (multiple comparisons)
among the groups of treatment means, the Tukey HSD test can be applied. For both tests the
following assumptions need to be satisﬁed: (i) the tested observations are independent both within
and among the groups, (ii) the data are normally distributed, and (iii) the variance within the
compared groups is equal.
The BestKeeper software (Pfa et al., 2004) is an Excel-based tool, that can be used to
determine the stability of reference genes. From the CT values, the geometric and arithmetic mean,
the standard deviation and the coeﬃcient of variation are derived. The BestKeeper software ranks
the reference genes by their standard deviation (Marouﬁ et al., 2010). The most stable reference
genes are the ones with lowest standard deviation. Only reference genes with a standard deviation
below 1 should be included in further analysis (Pfa et al., 2004). Repeated pairwise correlation
analysis of the reference genes are made to estimate the inter-gene relations resulting in coeﬃcient
of correlation values (r). The reference genes with the strongest correlations are combined into the
BestKeeper index. The BestKeeper index is the geometric mean of those genes. To evaluate the
stability of the individual reference genes pair-wise, the correlations between the reference genes
and the BestKeeper index (BKI) are calculated.
NormFinder is a free Excel-addin (Andersen et al., 2004) that can be used to identify the
stability of reference genes. The tested reference genes are ranked according to their stability.
Furthermore, intra- and intergroup variations can be studied (Kozera and Rapacz, 2013). According
to Andersen et al. (2004), expression variations in the reference genes have to be considered. All
reference genes will show some variations due to diﬀerent groups in a sample, e.g. normal and tumor
tissue, or other biological or experimental factors. The idea behind the NormFinder algorithm is
to select reference genes based on a model-based approach. By using this approach, it is possible to
estimate the overall expression variation of reference genes and also variations between subgroups
of a sample set. The stability of reference genes is indicated by a stability value.
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Application For validating the stability of the reference genes in the experimental conditions,
the ANOVA and Tukey HSD test was used. The assumptions needed to be fulﬁlled for using these
tests. To check if the data are normally distributed, the Shapiro-Wilk normality test was used and
to evaluate the assumption of equal variances, the Levene test was applied. The Tukey HSD test
was only applied if the ANOVA revealed that the treatment means in a gene diﬀer signiﬁcantly
from each other.
To determine the stability of the reference genes by using the BestKeeper software, for each
experiment the average CT values from all reactions were used to calculate the standard deviation.
Reference genes with standard deviations below 1 were used in further analysis. For reference
genes that fulﬁll this criteria, the pairwise correlation between the individual reference gene CT
value and the BestKeeper index was calculated using the BestKeeper software.
For determining the stability of the potential reference genes by using NormFinder software,
the input data have to be on a linear scale and raw CT values cannot be used directly. Since
the ampliﬁcation eﬃciency of the reference genes was approximately 100%, the CT values were
linearized by 2−CT and the data were entered into NormFinder (Andersen et al., 2004).
2.5.3 Normalization process
Theory Single or combined reference genes that are expressed at a constant level given treat-
ments are used to normalize the gene expression of the target gene. The reference genes used for
normalization depend on the results obtained in the previous step in which the stability of the
reference genes is tested. The arithmetic mean of the most stable reference genes can be used to
combine reference genes.
Application Many experiments were carried out before the normalization analysis was ﬁnalized.
In these experiments, only 18S rRNA andGAPDH were used as reference genes. In order to analyze
the inﬂuence of using single, potentially unstable reference genes, the normalization analysis were
carried out using the following set-up: (i) arithmetic mean of 18S rRNA, B2M, and ACTB, (ii)
arithmetic mean of GAPDH, 18S rRNA, B2M, and ACTB, (iii) only GAPDH, and (iv) only
18S rRNA.
2.5.4 2−∆∆CT method
Theory Data from RT-qPCR experiments can be analyzed using the 2−∆∆CT method which is
also called Livak method (Livak and Schmittgen, 2001). This method assumes that the ampliﬁca-
tion eﬃciencies of target and reference are near 100%. Table 3 shows the required CT values when
25
Table 3: Required information for relative quantiﬁcation using reference genes as normalizers.
Sample Gene
Target gene (tar) Reference gene (ref)
Control (con) CT (tar,con) CT (ref,con)
Treatment (treat) CT (tar,treat) CT (ref,treat)
Adapted from Bio-Rad Laboratories (2006)
relative quantiﬁcation is normalized by reference genes and the 2−∆∆CT method is used. In the
following the 2−∆∆CT method will be described for the most simple example  one target and one
reference gene, one test and one calibrator sample.
The 2−∆∆CT method consists of three steps. In the ﬁrst step the CT value of the target gene
is normalized to the CT value of the reference gene
∆CTcon = CT (tar,con) − CT (ref,con) (9)
∆CTtreat = CT (tar,treat) − CT (ref,treat). (10)
In the second step ∆CTtreat is normalized given ∆CTcon
∆∆CT = ∆CTtreat −∆CTcon. (11)
In the third and last step, the fold change is calculated as the expression diﬀerence between the
two genes in the two samples
Fold change = 2−∆∆CT . (12)
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Figure 9: The inhibitory eﬀect of diﬀerent butyrate concentrations on cell proliferation of HT-29,
Caco-2 and HCT-116 cells using the MTT assay. The graph shows the mean and the standard
deviation (n=6) for three independent cell experiments with two parallels. The horizontal gray
line at 80% cell viability indicates the highest acceptable inhibitory eﬀect of butyrate on the cell
lines.
3 Results
3.1 MTT assay
The MTT assay was used to test the cytotoxic eﬀect of diﬀerent butyrate concentrations on colon
carcinoma cells of the cell lines HT-29, Caco-2 and HCT-116. The cells were treated with butyrate
at various concentrations (0.5, 1.0, 2.5, 5.0, 7.5, 10.0 and 20.0 mM). The cell viability was deter-
mined after 24 hours with treatment (Figure 9). The butyrate concentration was considered to be
too toxic, if the cell proliferation was inhibited by more than 80%. Even though all three cell lines
responded diﬀerently to the butyrate treatment, the cell viability decreased in a dose-dependent
manner for all. Treatment with 20 mM butyrate inhibited the growth of HCT-116 cells by ap-
proximately 55% while the same butyrate concentration reduced the cell viability of HT-29 and
Caco-2 cells by 40% and 20%, respectively. To allow comparability, a butyrate concentration of
2.5 mM was chosen for all following experiments. The treatment time for HCT-116 cells in later
experiments was less than 24 hours and therefore 2.5 mM butyrate was assumed as suitable.
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Figure 10: Ampliﬁcation plot for ACTB for a 10-fold dilution series visualized in the software
SDS version 2.4.
3.2 RT-qPCR
3.2.1 Experimental treatment for 24 hours on HT-29 cells
PCR ampliﬁcation eﬃciency One assumption in RT-qPCR is that the PCR eﬃciency is
equal for target and reference genes. The PCR eﬃciency can be aﬀected by not properly designed
primers or probes as well as suboptimal PCR conditions. A pooled cDNA sample from one HT-29
cell experiment with 24 hours of incubation was therefore used for a crude evaluation of PCR
eﬃciencies of the four candidate reference genes by constructing a three-point standard curve with
10-fold dilutions. Figure 10 shows the ampliﬁcation plots of the dilution series of ACTB.
The obtained threshold cycles of the ACTB dilution series are plotted against the dilution of
the sample (Figure 11).
Properties of the estimated standard curves for the analyzed reference genes are shown in Ta-
ble 4. All reference genes, except 18S rRNA, were within the acceptable %E range of 100% ± 10%.
18S rRNA was with 111% just slightly outside the acceptable range.
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Figure 11: Standard curve for ACTB with three data points covering a 10-fold dilution series.
The value for the slope is -3.351 and the coeﬃcient of determination 0.99.
Table 4: Standard curve and eﬃciency for reference genes.
Gene Slope
Coeﬃcient of
determination
Eﬃciency (%)
GAPDH -3.435 0.994 95.5
18S rRNA -3.084 0.998 111.0
B2M -3.169 0.999 107.0
ACTB -3.351 0.999 98.8
Stability of reference genes in the HT-29 cell line The stability of the four reference genes
GAPDH, 18S rRNA, B2M, and ACTB was evaluated in HT-29 cells treated for 24 hours with
either 2.5 mM butyrate, 1 mg mL−1 dispersible wellmune, or untreated medium (see Table 1 for
technical or biological replicates). The expression level of the reference genes was measured using
RT-qPCR.
The variations among the CT values for each treatment are shown in Figure 12. This ﬁgure al-
lows a visual assessment of the potential reference genes within the experimental treatments. B2M
and ACTB clearly show more variations in their expression levels across the diﬀerent treatments
than 18S rRNA and GAPDH. In order to support the visual inspection (Figure 12) by statistical
inference, an ANOVA followed by a Tukey HSD test was applied. Shapiro-Wilk's test and the Lev-
ene's test were used to evaluate the assumptions of normally distributed data and equal variances,
which are essential for a correct application of ANOVA. The ANOVA showed that there was no
signiﬁcant diﬀerence in gene expression between butyrate, dispersible wellmune and no treatment
at a 0.05 level of signiﬁcance. Therefore the Tukey test was not needed. The Shapiro-Wilk's and
Levene's test suggested that the assumptions of the ANOVA were not violated.
The BestKeeper software determines the most stable reference genes by calculating the standard
deviation of input CT values and the pair-wise correlation analysis between reference genes and the
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Figure 12: Boxplot of CT values from RT-qPCR analysis of the four reference genes 18S rRNA,
B2M, ACTB, and GAPDH in HT-29 cells after 24 hours with butyrate (denoted B), dispersible
wellmune (denoted W), and no treatment (denoted C). The horizontal lines within the boxes
represent the median expression levels of the candidate reference genes while the boxes represent
the 25% and 75% percentiles. The whiskers represent the range of the expression levels. Each box
represents six data points resulting from three independent experiments.
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Table 5: Descriptive statistics of the CT for the four reference genes using BestKeeper software
(n=17, resulting from three independent experiments).
GAPDH 18S rRNA B2M ACTB
GM 22.35 15.74 26.01 21.90
SD 0.43 0.29 0.59 0.61
CV 1.92 1.83 2.27 2.78
Abbreviations: n = number of samples, GM = geometric mean of CT , SD = standard deviation of CT ,
CV (%) = coeﬃcient of variation (SD expressed as percentage of GM).
Table 6: Stability of potential reference genes in HT-29 cells using BestKeeper (n=17) and
NormFinder (n≥5).
Gene name
Stability value
(BestKeeper)
Ranking
(BestKeeper)
Stability value
(NormFinder)
Ranking
(NormFinder)
GAPDH -0.32 4 0.24 4
18S rRNA 0.82 2 0.09 1
B2M 0.94 1 0.18 3
ACTB 0.62 3 0.16 2
A ranking of 1 indicates the most stable reference gene.
BestKeeper index. The lowest variation was observed for 18S rRNA while ACTB had the highest
variation, with standard deviations of 0.29 and 0.61, respectively (Table 5).
All tested reference genes had standard deviations below 1. Therefore, all reference genes were
used for further analysis. The highest correlations were obtained for B2M and 18S rRNA. GAPDH
was ranked as the least stable reference gene (Table 6).
The NormFinder software selects the most stable reference genes using a model-based approach.
The results were partly in accordance with the results obtained with BestKeeper but showed also
diﬀerences. For instance, B2M which was ranked as the most stable reference gene in the Best-
Keeper software, was only the third-most stable reference gene in the NormFinder software. The
most stable reference gene with the lowest stability value was 18S rRNA. GAPDH was identiﬁed
as the least stable gene by NormFinder which is in accordance with the results in the BestKeeper
software (Table 6). Additionally, GAPDH had the highest inter- and intragroup variations.
According to the results of BestKeeper and NormFinder, GAPDH  one of the most commonly
used reference genes  should be avoided for the normalization in this study. The BestKeeper
software requires manually elimination of less suitable reference genes to avoid stability variations
that are biased due to high intergroup variations. The BestKeeper analysis was therefore repeated
without GAPDH. The correlation between the remaining genes increased clearly (0.85 < r < 0.97).
It can be concluded that GAPDH should not be used as reference gene.
Fold changes after experimental treatment for 24 hours on HT-29 cells In order to
evaluate the practical signiﬁcance of the results above, normalization of target gene expression in
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Table 7: Descriptive statistics of fold changes given diﬀerent treatments. Each statistic is based
on six observations consisting of three experiments and two biological parallels.
Gene PTGS2 NF-κB1 NFE2L2
Treatment B W B W B W
Mean 0.32 0.48 0.24 0.53 0.92 1.91
3 reference genes SD 0.08 0.19 0.03 0.09 0.19 0.44
p-value <0.001 0.007 <0.001 0.001 0.24ns 0.013
Mean 0.31 0.43 0.23 0.47 0.87 1.69
4 reference genes SD 0.08 0.18 0.03 0.09 0.19 0.44
p-value <0.001 0.004 <0.001 0.001 0.133ns 0.025
mean 0.27 0.38 0.18 0.30 0.66 1.05
GAPDH SD 0.07 0.23 0.03 0.08 0.18 0.38
p-value <0.001 0.001 <0.001 <0.001 0.03 0.393ns
Mean 0.33 0.39 0.25 0.45 0.94 1.63
18S rRNA SD 0.08 0.15 0.02 0.12 0.19 0.49
p-value <0.001 0.002 <0.001 0.002 0.298ns 0.041
p-values indicate the signiﬁcance level of one-sided t-tests for the diﬀerence between the mean and
1.
Abbreviations: SD = Standard deviation; ns = not signiﬁcant at the 95% conﬁdence level; 3 reference
genes = arithmetic mean of 18S rRNA, ACTB, B2M ; 4 reference genes = arithmetic mean of GAPDH, 18S
rRNA, ACTB, B2M ; Treatment = cells treated with butyrate (denoted B) or dispersible wellmune (denoted
W).
HT-29 cells treated with butyrate or dispersible wellmune for 24 hours was performed in diﬀerent
ways. First, the arithmetic mean of CT values of 18S rRNA, B2M, and ACTB was used for
normalization. The results of this normalization are shown in (Figure 13A and Table 7). A
signiﬁcant down-regulation of the gene expression of NF-κB1 and PTGS2 in response to butyrate
and dispersible wellmune can be seen there. NFE2L2 gene expression on the other hand was
up-regulated by dispersible wellmune, but unaﬀected by butyrate.
Using all four reference genes for normalization, resulted in essentially the same as using three
reference genes (Figure 13B and Table 7).
The same was the case if 18S rRNA was used as single reference gene for normalization (Fig-
ure 13D and Table 7).
By using GAPDH as a single reference gene for normalization the same results as for nor-
malization with the three most stable or all four reference genes were obtained for NF-κB1 and
PTGS2. However in contrast to this, NFE2L2 appeared to be signiﬁcantly down-regulated in the
butyrate treated samples and not signiﬁcantly up-regulated in the dispersible wellmune treated
samples (Figure 13C and Table 7).
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Figure 13: Boxplots of fold changes resulting from RT-qPCR analysis of PTGS2, NF-κB1, and
NFE2L2 in HT-29 cells after 24 hours treatment with butyrate (denoted B) or dispersible wellmune
(denoted W). Each box represents six data points resulting from three independent experiments.
The horizontal lines within the boxes represent the median expression levels of the candidate
reference genes while the boxes represent the 25% and 75% percentiles. The whiskers represent the
range of the expression levels. A: The arithmetic mean of 18S rRNA, B2M, and ACTB was used
for normalization. B: The arithmetic mean of GAPDH, 18S rRNA, B2M, and ACTB was used
for normalization. C: GAPDH was used for normalization. The circles indicate potential outliers
which are more than 1.5 times the interquartile range above the box. D: 18S rRNA was used for
normalization.
33
B W B W B W
0.0
0.5
1.0
1.5
2.0
A: 18S for normalization, 3h
Treatment
Fo
ld
 c
ha
ng
e
PTGS2 NF−kB1 NFE2L2
B W B W B W
0.0
0.5
1.0
1.5
2.0
B: 18S for normalization, 6h
Treatment
Fo
ld
 c
ha
ng
e
PTGS2 NF−kB1 NFE2L2
Figure 14: Boxplots of fold changes resulting from RT-qPCR analysis of PTGS2, NF-κB1, and
NFE2L2 in HT-29 cells after treatment with butyrate (denoted B) or dispersible wellmune (de-
noted W). Each box is based on two observations resultnig from one experiment and two biological
parallels. The horizontal lines within the boxes represent median expression levels while the boxes
represent the 25% and 75% percentiles. A: 18S rRNA was used as reference gene. Treatment time
was three hours. B: 18S rRNA was used as reference gene. Treatment time was six hours.
3.2.2 Experimental treatment for three and six hours on HT-29 cells
Fold changes after experimental treatment for three or six hours on HT-29 cells In a
pre-experiment on diﬀerent incubation times, the gene expression of PTGS2, NF-κB1, and NFE2L2
was studied by using only 18S rRNA for normalization. HT-29 cells were treated for three hours or
six hours with butyrate or dispersible wellmune. The cell experiment was conducted only once (see
Table 1). Due to the small number of observations (n=2) no statistical analysis was performed,
but the results are displayed graphically in Figure 14. Relative changes in the gene expression of
the target genes after three hours with treatment are shown in Figure 14A. PTGS2 and NF-κB1
gene expression were down-regulation after three hours incubation with butyrate while no distinct
changes were observable for the dispersible wellmune treatment. The range in the fold change of
both genes after the dispersible wellmune treatment was considerably larger than for the butyrate
treatment. NFE2L2 displayed a slight tendency for up-regulation after both treatments.
In Figure 14B, the relative gene expression of the three genes of interest is shown after six hours
with butyrate or dispersible wellmune treatment. The gene expression of these genes was inhibited
by the butyrate treatment. As for the dispersible wellmune treatment for three hours, there is no
change in the gene expression level in PTGS2 and NF-κB1 after six hours. The tendency of an
increased NFEL2L gene expression observed after three hours treatment with dispersible wellmune
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Figure 15: Boxplot of CT values from RT-qPCR analysis of the four reference genes 18S rRNA,
B2M, ACTB, and GAPDH in HCT-116 cells after six hours with butyrate (denoted B), dispersible
wellmune (denoted W), and no treatment (denoted C). The horizontal lines within the boxes
represent the median expression levels of the reference genes while the boxes represent the 25%
and 75% percentiles. The whiskers represent the range of the expression levels. Each box represents
four data points resulting from two independent experiments.
is strengthened after six hours. Again, the range in the fold change in the target genes after the
dispersible wellmune treatment was considerably larger than after the butyrate treatment.
3.2.3 Experimental treatment for six hours on HCT-116 cells
Stability of reference genes in HCT-116 cell line After treating HCT-116 cells for six hours
with either 2.5 mM butyrate or 1 mg mL−1 dispersible wellmune, the stability of the four reference
genes GAPDH, 18S rRNA, B2M, and ACTB was evaluated. The expression level of the reference
genes was measured using RT-qPCR and their stability was tested by three diﬀerent approaches.
Figure 15 shows the variations among the CT values for each treatment. This ﬁgure allows a
visual assessment of the potential reference genes given the experimental treatments. The ANOVA
revealed no signiﬁcant diﬀerence between treatments in the genes B2M and ACTB while signiﬁ-
cant diﬀerences occurred in GAPDH and 18S rRNA (Table 8). The Tukey HSD test clariﬁed that
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in GAPDH, the gene expression level between the control and the butyrate and dispersible well-
mune treatment were signiﬁcantly diﬀerent. There was no signiﬁcant diﬀerence in gene expression
between dispersible wellmune and butyrate. In 18S rRNA, the dispersible wellmune treatment
diﬀered signiﬁcantly from the control. There were no signiﬁcant diﬀerences between the other
treatments (Table 8).
Table 8: ANOVA and Tukey HSD tests measurements of signiﬁcant group mean diﬀerences of
reference genes in HCT-116 cells.
Gene name
p-value
ANOVA
Treatment
comparision
p-value
Tukey HSD test
C-B 0.008s
GAPDH 0.009s W-B 0.596
W-C 0.031s
C-B 0.282
18S rRNA 0.034s W-B 0.317
W-C 0.027s
C-B 0.872
B2M 0.337 W-B 0.286
W-C 0.527
C-B 0.955
ACTB 0.654 W-B 0.641
W-C 0.806
p-values indicate the signiﬁcance level of ANOVA or Tukey HSD test for the diﬀerence between the various
treatments in a gene. Abbreviations: s = signiﬁcant diﬀerence between treatments in the speciﬁc gene on
a 95% signiﬁcance level, C = control, W = dispersible wellmune, B = butyrate.
The BestKeeper software showed the lowest variation for GAPDH while ACTB had the highest
variation, with standard deviations of 0.15 and 0.22, respectively (Table 9). Since the standard
deviation for all reference genes was below 1, all reference genes were used for further analysis. The
BestKeeper software revealed that the highest correlations were obtained for 18S rRNA and B2M
while GAPDH was ranked as the least stable reference gene (Table 10). BestKeeper suggests that
GAPDH should be avoided as reference gene for normalization. When omitting GAPDH as the
least stable reference gene from the BestKeeper analysis, the correlation between the remaining
genes increased slightly (0.65 < r < 0.88).
The results of the NormFinder software were partly in accordance with the results obtained
using BestKeeper. GAPDH was identiﬁed as the least stable reference gene by both softwares. Its
stability value was however only slightly worse than for the other genes. Additionally, GAPDH
had the highest inter- and intragroup variation. ACTB was ranked as the most stable reference
gene in the NormFinder software while it was only the third most stable reference gene when the
BestKeeper software was used.
As for the HT-29 cells, it can be concluded that GAPDH is the least stable reference gene.
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Table 9: Descriptive statistics of CT values in HCT-116 cells for four candidate reference genes
using BestKeeper software (n=12).
GAPDH 18S rRNA B2M ACTB
GM 22.25 15.41 27.09 22.16
SD 0.15 0.16 0.20 0.22
CV 0.67 1.04 0.91 0.80
Abbreviations: n = number of samples, GM = geometric mean of CT , SD = standard deviation of CT ,
CV = coeﬃcient of variation (SD expressed as percentage of the geometric mean).
Table 10: Stability of potential reference genes in HCT-116 cells using BestKeeper (n=12) and
NormFinder (n=4).
Gene name
Stability value
(BestKeeper)
Ranking
(BestKeeper)
Stability value
(NormFinder)
Ranking
(NormFinder)
GAPDH 0.19 4 0.09 4
18S rRNA 0.78 1 0.07 2
B2M 0.74 2 0.08 3
ACTB 0.59 3 0.06 1
A ranking of 1 indicates the most stable reference gene.
Fold changes after experimental treatment for six hours on HCT-116 cells The ampliﬁ-
cation of PTGS2 occurred later than expected. The CT values were between 35 and 37 (Table 11).
For TaqMan assays the cut-oﬀ is 35 cycles. Everything above this number of cycles is considered
to be unreliable detections of gene expressions. Since the CT values of PTGS2 were above the
acceptable cut-oﬀ level, the data were not used for fold change calculations.
When RT-qPCR was performed on cDNA from HCT-116 cells treated with butyrate for six
hours and the arithmetic mean of 18S rRNA, B2M, and ACTB was used for normalization, the
treatment led to a signiﬁcant down-regulation of NF-κB1 and NFE2L2. The treatment of HCT-
116 cells with dispersible wellmune led to no signiﬁcant changes inmregulation of the NF-κB1 gene,
while NFE2L2 was signiﬁcantly up-regulated (Figure 16A and Table 12).
The BestKeeper software ranked GAPDH as unstable reference gene. To determine the impact
of using GAPDH anyways, the arithmetic mean of all reference genes was used for normalization.
As illustrated in Figure 16 and Table 12, the use of three (without GAPDH ), four (with GAPDH )
or only one (GAPDH ) reference gene for normalization had little impact on the resulting fold
change expressions of the target genes. All three normalization alternatives revealed a signiﬁcant
reduction of NF-κB1 and NFE2L2 gene expression by butyrate treatment and a signiﬁcant increase
Table 11: Mean and standard deviations of CT values in HCT-116 cells after six hours with
butyrate, dispersible wellmune, and no treatment (control) (n=4).
Treatment Mean Standard deviation
Control 36.84 0.21
Butyrate 34.82 0.13
Dispersible wellmune 35.07 0.39
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Table 12: Descriptive statistics of fold changes given diﬀerent treatments in HCT-116 cells. Each
statistic is based on four observations consisiting of two experiments and two parallels.
Gene NF-κB1 NFE2L2
Treatment B W B W
Mean 0.51 0.93 0.45 1.64
3 reference genes SD 0.05 0.19 0.04 0.18
p-value <0.001 0.253ns <0.001 0.003
Mean 0.56 0.97 0.51 1.72
4 reference genes SD 0.07 0.14 0.08 0.06
p-value <0.001 0.364ns 0.001 <0.001
mean 0.61 0.91 0.55 1.59
GAPDH SD 0.01 0.18 0.01 0.99
p-value 0.005 0.179ns 0.003 0.003
p-values indicate the signiﬁcance level of one-sided t-tests for the diﬀerence between the mean and
1.
Abbreviations: SD = Standard deviation; ns = not signiﬁcant at the 95% conﬁdence level; 3 reference
genes = arithmetic mean of 18S rRNA, ACTB, B2M ; 4 reference genes = arithmetic mean of GAPDH, 18s
rRNA, ACTB, B2M ; Treatment = cells treated with butyrate (denoted B) or dispersible wellmune (denoted
W).
in NFE2L2 gene expression by dispersible wellmune treatment. No signiﬁcant eﬀect of dispersible
wellmune treatment in NF-κB1 gene expression could be observed.
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Figure 16: Boxplots of fold changes resulting from RT-qPCR analysis of NF-κB1 and NFE2L2
in HCT-116 cells after six hours treatment with butyrate (denoted B) or dispersible wellmune
(denoted W). Each box represents four data points resulting from two independent experiments.
The horizontal lines within the boxes represent the median expression levels of the reference genes
while the boxes represent the 25% and 75% percentiles. The whiskers represent the range of
the expression levels. A: The arithmetic mean of 18S rRNA, B2M, and ACTB was used for
normalization. B: The arithmetic mean of GAPDH, 18S rRNA, B2M, and ACTB was used for
normalization. C: GAPDH was used for normalization.
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4 Discussion
4.1 MTT assay
To study the eﬀect of butyrate as one of the important dietary ﬁber fermentation metabolites on
key aspects of gene expression in colon cancer cell lines, a butyrate concentration was needed which
was high enough to cause alterations in gene expression and low enough to avoid apoptosis. The
MTT assay was used to ﬁnd a concentration that fulﬁlled these constraints by analyzing changes in
the cell viability due to diﬀerent butyrate concentrations. The butyrate concentration was assumed
to be too toxic if the cell viability dropped below 80% after 24 hours with treatments in HT-29,
HCT-116, and Caco-2 cells. For HT-29 cells, concentrations up to 2.5 mM butyrate fulﬁlled the
80% requirement. These results are in accordance with the study of Siavoshian et al. (2000), who
demonstrated that HT-29 cells, treated with butyrate for three days started an inhibition in cell
growth at 1 mM. A complete inhibition was observed at a concentration of 8 mM butyrate.
In this thesis, Caco-2 cells were not found to be responsive to butyrate treatment after 24 hours
and were therefore not considered in further analysis. Blok (2002, p.80) treated Caco-2 cells for
two to 19 days with butyrate and observed that 2 mM butyrate had no eﬀect on cell proliferation.
A strong cell growth inhibiting eﬀect was seen with 10 mM butyrate in the same time-period. This
suggests that Caco-2's response to butyrate treatment is slower which could be considered in future
studies.
Butyrate reduced HCT-116 cell proliferation at very low levels in this thesis. Already the lowest
butyrate concentration tested, resulted in a cell proliferation below the 80% requirement. The study
of Fung et al. (2011) supports this observation. In their study, a 2.5 mM butyrate treatment for
24 hours induced cell apoptosis and inhibited cell proliferation. In the present study, HCT-116
cells reacted more sensitive on a butyrate treatment than HT-29 and Caco-2 cells. According to
ATCC, the provider of the cell lines, HT-29 and Caco-2 cells have mutations in the p53 gene, while
HCT-116 has not. This could be one of the reasons for the observed diﬀerent responsiveness of
the cell lines to butyrate, because diﬀerences in p53 gene mutations have previously been shown
to be important for speciﬁc cell line characteristics. Yao et al. (2005) have, for example, tested
the adaption of tumor cells to hypoxia (lower oxygen concentration in the arterial blood than
normal) by recreating in vitro situations of chronic exposure to low-oxygen levels. They found
that HT-29 cells became more resistant to hypoxia while HCT-116 cells became more sensitive to
hypoxia. The diﬀerence in the p53 gene between the cell lines was hypothesized to account for the
contrary directions of sensitivity to hypoxia. This hypothesis was supported by their observation
that HCT-116 cells with knocked out p53 changed their hypoxia sensitivity and react in the same
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way as HT-29 cells.
To obtain comparable results, a butyrate concentration of 2.5 mM was used in all further
experiments, even though this may be suboptimal for HCT-116 cells and treatments of 24 hours.
Because HCT-116 cells were always treated less than 24 hours, is was assumed that the butyrate
concentration was acceptable.
4.2 Adaption of RT-qPCR method
RT-qPCR is a commonly used technique for measuring quantiﬁcation of gene expression. For the
adaption of a RT-qPCR analysis, a variety of decisions have to be made: when (i) isolating RNA
from a sample, (ii) reverse transcribing the RNA into cDNA, and (iii) amplifying the cDNA in a
PCR. In the following section, the most important decisions and requirements made in this thesis
will be discussed. The discussion is meant to help adapting the developed method for others than
the tested dietary ﬁber.
RNA isolation The preparation of a proper RNA sample is the ﬁrst fundamental step in adapt-
ing a RT-qPCR method. Isolated RNA is strongly exposed to RNA degradation by RNases. For
avoiding degradation, RNase inhibitors were used in this thesis. Furthermore, genomic DNA con-
taminations need to be avoided because these could result in false positive signals in the later
PCR. According to McPherson and Møller (2006), genomic DNA can never be completely elimi-
nated from RNA preparations and a non-reverse transcriptase (NRT) sample should be included.
Such a sample includes all reagents apart from the reverse transcriptase. A ﬂuorescence signal
in this sample indicates a genomic DNA contamination. If the diﬀerence in the CT numbers is
greater than six between the target sample and the NRT sample, the genomic DNA contamination
will not inﬂuence the results of the relative gene expression analysis (Qiagen, 2013). In this thesis,
genomic DNA contaminations were eliminated by using a DNase treatment. The eﬀectiveness of
the DNase treatment was always evaluated by including a NRT sample in the analysis. In this
thesis no genomic DNA contaminations above the inﬂuencing threshold limit were found in any of
the samples.
The purity and concentration of a RNA sample can be determined by UV-Vis spectrophotome-
ter measurements. In this thesis the UV-Vis spectrophotometer NanoDrop ND-1000 was used.
By calculating the ratio of absorbance at 260 nm and 280 nm, the purity of RNA (or DNA) can
be estimated. A ratio appreciably lower than the reference (see p. 20) indicates protein contam-
inations. Furthermore, NanoDrop calculates the ratio of absorbance at 260 nm and 230 nm. A
ratio appreciably lower than the reference may indicate contaminations of reagents used in the
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RNA isolation. However, based on the experience made in this thesis, the use of these ratios to
estimate RNA purity in samples with RNA concentrations below 100 ng µL−1 was not straight-
forward. Furthermore, the NanoDrop spectrophotometer can only determine the purity of nucleic
acids and cannot distinguish between RNA and DNA. Genomic DNA contaminations are therefore
not detectable. For this reason, NanoDrop was primary used for measuring the concentration of
the RNA samples.
In this thesis, a RNA isolation kit provided by Qiagen (2012) was used. Several other companies
oﬀer kits for the same purpose, for example Agilent Technologies (2010) and Bio-Rad Laboratories
(2000). In the kit provided by Qiagen (2012), the biological sample is disrupted and cellular
components such as protein, DNA, and RNA are free in solution. Several puriﬁcation steps are
performed for obtaining pure RNA. RNA isolation kits are easy to use by following the provided
protocol. Furthermore, the reaction system is thoroughly tested and optimized by the provider
which enables optimal RNA yields. A disadvantage of the RNA isolation kit from Qiagen (2012) was
the incomplete indication of components in chemical solutions such as buﬀers. This complicated
the understanding of the necessity to use these solutions. When using a RNA isolation kit for the
ﬁrst time it is therefore very helpful to understand as much of the reaction system as possible for
preventing contaminations by RNase and genomic DNA.
cDNA synthesis The isolated RNA needs to be reverse transcribed into cDNA since only DNA
is a suitable template for later PCR ampliﬁcation. An important decision in cDNA synthesis is
the choice of primers. Advantages and disadvantages when choosing sequence speciﬁc, oligo(dT),
or random hexamer primers are mentioned on page 8. In this thesis random hexamer primers
were used since one of the reference genes was of type rRNA and not mRNA. The poly(A) tail is
missing in rRNA and the oligo(dT) primer is therefore not suitable. It can be expected that no
speciﬁc PCR ampliﬁcation of the rRNA gene would be possible if oligo(dT) primers were used.
Resuehr and Spiess (2003) tested the eﬀect of oligo(dT) and random hexamer priming and found
that a combination of oligo(dT) and random hexamer was the best suitable approach in cDNA
synthesis. Therefore, it may be advisable to follow the approach of Resuehr and Spiess (2003) to
get the beneﬁt of both primers in future studies.
PCR Another important decision in the RT-qPCR process was the choice of the appropriate
temperature and PCR conditions. According to Roux (2009), the choice of not suitable temper-
ature settings may lead to ampliﬁcation of nonspeciﬁc PCR products or no ampliﬁcation of the
desired product. In this thesis, temperature conditions for primer, probe and thermostable DNA
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polymerase were used as recommended by the provider of the PCR kit (TaqMan Life Technologies,
2011). The test of the PCR ampliﬁcation eﬃciency proved that the chosen temperature conditions
were suitable for the PCR.
Equal PCR eﬃciencies in all reference and target genes are important to allow a reliable com-
parison between samples. Since the PCR is of exponential nature, diﬀerences in the eﬃciencies
can lead to error-prone estimates of expression ratios. The eﬃciency test is especially important
if manually designed primers are used instead of commercial predesigned primers. In this thesis,
predesigned TaqMan Gene Expression Assays were used and a measurement of the PCR eﬃciency
is actually not necessary. Thermo Fisher Scientiﬁc validated their assays extensively and guarantee
a PCR eﬃciency of 100% ± 10% in samples free of PCR inhibitors (TaqMan Life Technologies,
2012). However, the PCR eﬃciencies of the candidate reference genes were determined nonetheless
in order to check whether the PCR conditions were optimal. An eﬃciency between 90% and 110%
is supposed to be optimal for PCR (Garson et al., 2009). All tested reference genes achieved PCR
eﬃciencies in this range, except for 18S rRNA which was slightly out of range with 111%. For
estimating the eﬃciency, standard curves were generated but these standard curves consisted of
only three points in a 10-fold dilution series. This is a quite low number of points and it is more
commonly referred to standard curves consisting of ﬁve or more points (e.g. Dorak, 2006). The
explanatory power of standard curves with three points is lower than those with ﬁve or more points.
Given that the eﬃciency of 18S rRNA is just marginally out of range and the test was based on
small dilution series, it was nevertheless accepted as suﬃcient. The PCR eﬃciency for the three
target genes NF-kB1, PTGS2, and NFE2L2 was assumed to be 100% ± 10% as guaranteed by
Thermo Fisher Scientiﬁc and not further analyzed. The results of the PCR eﬃciency revealed,
that the PCR conditions were suﬃcient.
All the decisions and requirements mentioned above are important for analyzing the stability
of reference genes. Unfortunately, these information are often not mentioned in the literature.
4.3 Stability of reference genes
Comparison with other studies Reference genes used for normalization in RT-qPCR need
to fulﬁll several criteria. One criterion is the stable expression under diﬀerent experimental treat-
ments. The expression stability can be determined by using diﬀerent statistical and mathematical
algorithms. In this thesis, four reference genes were tested for their stability under the experimen-
tal conditions by using three diﬀerent validation methods as advised by Kozera and Rapacz (2013).
The four reference genes were GAPDH, 18S rRNA, B2M, and ACTB. In this section the ﬁndings
of other studies that evaluated the stability of these reference genes will be discussed.
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Because GAPDH is one of the most commonly used reference genes in RT-qPCR in general
(e.g., Edwards and Denhardt, 1985; Winer et al., 1999) it was also used. In the course of this thesis,
it turned out that GAPDH is often described as unstable in studies with colorectal cancer tissue
and colon cancer cell lines. Dydensborg et al. (2006) showed altered GAPDH gene expression
between normal and colon tumor tissue. Ersahin et al. (2014) worked with human cancer cell lines
and described novel reference genes. They report that GAPDH was a stable reference gene in liver
cancer cell lines but not in breast and colon cancer cell lines.
The study of Ersahin et al. (2014) showed that ACTB was a stable reference gene in colon cancer
cell lines. This was conﬁrmed by Duary et al. (2014) who evaluated ACTB as one of the most
stable reference genes in a study were the expression of pro-inﬂammatory and anti-inﬂammatory
genes in HT-29 cells were tested on two potential probiotic strains.
The studies of Dydensborg et al. (2006) and Kheirelseid et al. (2010) showed the suitability
of B2M as reference gene. Dydensborg et al. (2006) found that B2M was the best-suited gene
for normalization when the objective was to analyze the gene expression between healthy and
adenocarcinomas in the human colon. B2M was one of the two most stable reference genes out of
13 in the study of Kheirelseid et al. (2010) who evaluated suitable reference genes for comparing
primary colorectal tumor and tumor associated normal tissue.
Several studies advised to use the reference gene 18S rRNA with care. Dijkstra et al. (2014)
critically reviewed quantitative PCR results in colorectal cancer research and pointed out that
18S rRNA should only be used as reference gene after an accurate validation process. Furthermore,
it should never be used as single reference gene. One problem of using 18S rRNA as a reference
gene is that the rRNA synthesis is independent of the synthesis of mRNA due to diﬀerent RNA
polymerases. This may result in diﬀerences in expression patterns between the RNAs transcribed
by diﬀerent RNA polymerases (Radoni¢ et al., 2004).
Methodological aspects Three diﬀerent statistical methods were used to analyze the stability
of the potential reference genes. In this section, the advantages and disadvantages of the methods
will be discussed. No signiﬁcant diﬀerences in gene expression of the four reference genes were found
in HT-29 cells after diﬀerent treatments when analyzing the data with ANOVA and Tukey HSD
tests. In HCT-116 cells the ANOVA and Tukey HSD test suggest that GAPDH and 18S rRNA were
not expressed in a stable manner under the experimental treatments. One possible explanation for
the observed instability of 18S rRNA and GAPDH in HCT-116 but not HT-29 cells can be the
lower number of observations in HCT-116 cells (n=4) compared to HT-29 cells (n=6).
The stability of the four reference genes was further tested by using two of the most commonly
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used free software programs, BestKeeper and NormFinder. The two approaches did not rank
the stability of the reference genes in the same way. According to the BestKeeper software, the
most stable reference gene was B2M in HT-29 cells and 18S rRNA in HCT-116 cells. Opposed to
that, the NormFinder software identiﬁed 18S rRNA as the most stable reference gene in HT-29
cells and ACTB in HCT-116 cells. Both, BestKeeper and NormFinder, identiﬁed GAPDH as the
least stable reference gene in HT-29 and HCT-116 cells. According to Anstaett et al. (2010), the
diﬀerent results in the BestKeeper and NormFinder software occur due to diﬀerent algorithms used
in the calculation of the gene stability. There is no consensus in literature whether BestKeeper
or NormFinder is preferable for validating the stability of reference genes. Both are however
better suited than the ANOVA and Tukey HSD test because they consider the relation between all
reference genes. Since BestKeeper and NormFinder generated similar results for the most stable
reference genes in this thesis, it was decided that the arithmetic mean of 18S rRNA, B2M, and
ACTB was best suited for normalization.
While ANOVA and Tukey HSD tests may be seen as a simple pre-analysis step for validating the
reference genes, the main focus should be put on the results of NormFinder and BestKeeper. All
statistical tests require enough observations to obtain reliable results. The number of observations
in this thesis are rather small and future studies would proﬁt from more observations.
Normalization After validating the reference genes with the statistical approaches discussed
above, GAPDH was found to be not optimally suited as reference gene. This observation brings
up the question of how reference genes that are less stable than they are supposed to be, inﬂuence
the normalization process. This question is of importance, if a proper validation of reference genes
is ignored (e.g., due to budgetary constraints). To test the eﬀect of unstable reference genes in
a gene expression experiment, diﬀerent combinations of reference genes, including the unstable
GAPDH, were used for normalization in this thesis.
In HT-29 cells, the same results were obtained when the relative expression of the target
genes was determined by using the 2−∆∆CT method, regardless of using the arithmetic mean of
the three most stable reference genes (18S rRNA, ACTB, and B2M ), the arithmetic mean of all
reference genes, or only 18S rRNA. However, when using only GAPDH as a single reference gene
in normalization, changes in gene expression in NFE2L2 due to the diﬀerent treatments were not
detectable. This observation points out the risk of using unstable reference genes for normalization.
This problem was not observed for HCT-116 cells for which the stability of the reference genes was
more homogenous.
In HT-29 cell experiments with three and six hours treatment time only the stability of
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18S rRNA and GAPDH was analyzed. The use of 18S rRNA as single reference gene for nor-
malization was suitable for these experiments as the results were in accordance with the results of
using the arithmetic mean of three reference genes.
4.4 Suitability and evaluation of the developed test system
The aim of this thesis was to establish a test system for studying speciﬁc molecular mechanisms
behind the potential protective eﬀect of certain dietary ﬁbers and their fermentation metabolites on
the development of colon cancer. Up- and down-regulations of individual target gene expressions
were observed after treatment with dispersible wellmune or butyrate.
One of the target genes was the transcription factor NF-κB, which is one of the key regulators
in innate immune response and inﬂammation (Sakamoto et al., 2009). The activation of the NF-κB
transcriptions factor promotes proliferation and prevents apoptosis of cancer cells (Hassanzadeh,
2011). The down-regulation of NF-κB1 gene expression observed in HT-29 cells after 24 hours
incubation with dispersible wellmune or butyrate in this thesis may therefore be one potential
mechanism by which dietary ﬁber protects against the development of colon cancer. As a key
regulator of innate immunity, NF-κB is also deeply involved in inﬂammation. Also in this respect
a down-regulation of NF-κB1 gene expression and in turn NF-κB activity may be protective,
since chronic inﬂammation is associated with the development of cancer (Balkwill and Mantovani,
2001; Coussens and Werb, 2002) and tumors create a pro-inﬂammatory environment to promote
progression and metastasis (Nelson and Ganss, 2006). An inhibition of NF-κB has been suggested
as a useful anti-tumor treatment and Sakamoto et al. (2009) found that the tumor expansion was
suppressed in in vivo cells with inhibited activation of NF-κB. The ﬁndings of this thesis are in
agreement with Yin et al. (2001) who showed that butyrate inhibits the activation of NF-κB in
HT-29 cells. An inhibitory eﬀect of dispersible wellmune on NF-κB activation has previously been
shown by Shah (2009) in microglia (primary immune cells of the central nervous system).
Another target gene was PTGS2, which is one of the genes regulated by NF-κB. PTGS2 is
involved in the development of cancer, cell transformation, and tumor growth (Chandrasekharan
and Simmons, 2004). Furthermore, PTGS2 is over-expressed in colorectal cancer (Eberhart et al.,
1994). It was shown that PTGS2 inhibitors inhibit intestinal polyps and colorectal tumors (Stein-
bach et al., 2000). In this thesis, the gene expression of the target genes NF-κB1 and PTGS2 was
down-regulated in HT-29 cells after treatment with butyrate or dispersible wellmune for 24 hours.
In the light of the studies cited above, these ﬁndings indicate that butyrate and dispersible well-
mune may act as anti-inﬂammatory agents in the tested human colon carcinoma cell lines.
The third target gene in this thesis encodes the transcription factor NFE2L2, which regulates
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more than 100 genes (Sporn and Liby, 2012). NFE2L2 has a protective eﬀect in suppressing
oxidative stress and inhibits carcinogenesis (Ramos-Gomez et al., 2001). There are abundant
indications that the activation of NFE2L2 suppresses carcinogenesis in an early state (Hayes et al.,
2010). Furthermore, drugs that enhance the activation of NFE2L2 have been shown to prevent
cancer (Kwak and Kensler, 2010). Taken the above mentioned studies as a basis, an up-regulation
in NFE2L2 gene expression indicates an anti-oxidative eﬀect. In this thesis, the gene expression of
NFE2L2 was up-regulated in HT-29 cells after 24 hours treatment with dispersible wellmune. No
signiﬁcant diﬀerence in gene expression was observed for the butyrate treatment after 24 hours.
All the observed eﬀects of dispersible wellmune and butyrate were dependent on the treatment
time. In HT-29 cells, three diﬀerent treatment times were tested. The results clearly showed
that the diﬀerent eﬀects on target gene expression occurred at diﬀerent time points. While the
inhibitory eﬀect of butyrate on NF-κB1 and PTGS2 gene expression was already detectable after
three hours, the inhibitory eﬀect of dispersible wellmune on the expression of those two genes
needed 24 hours to fully develop. The stimulating eﬀect of dispersible wellmune on NFE2L2 gene
expression, on the other hand, was already detectable after six hours. Incubation of HT-29 cells
with butyrate for six hours resulted in inhibition of NFE2L2 gene expression, an eﬀect that was
not observed with three or 24 hours incubation. These results show that the incubation time has
to be carefully selected in order to ﬁt the right time-window of the response. In this thesis, the
eﬀects observed on all target genes by the two treatments at earlier time points were still apparent
after 24 hours incubation with the exception of the inhibitory eﬀect of butyrate on NFE2L2 after
six hours. An incubation time of 24 hours seems therefore to be suﬃcient to detect the majority
of changes in gene expression and can be used as a screening incubation time in future studies.
For the HCT-116 cell line, only six hours with butyrate or dispersible wellmune treatment were
tested. The results of the six hours treatment time in HCT-116 cells were similar to the results of
the six hours treatment time in HT-29 cells. However, there was one exception. The CT values of
PTGS2 in HCT-116 cells were outside the cut-oﬀ level for TaqMan gene expression assays. This
observation indicates that PTGS2 is not or only in very low abundance expressed in this cell line.
This is in agreement with the ﬁndings by Park et al. (2003) who also found that PTGS2 is not
expressed in HCT-116 cells. Due to diﬀerent mutations in the HT-29 and HCT-116 cell line, they
should represent two diﬀerent colon cancer cell line models. However, both cell lines revealed the
same results in this thesis and it may be considered to use only the HT-29 cell line in future studies
because HCT-116 does not express all of the target genes.
As the developed test system was able to detect the potential protective eﬀects of the speciﬁc
dietary ﬁber dispersible wellmune and the known ﬁber metabolite butyrate, it may be well suited
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as a screening system for diﬀerent dietary ﬁbers and their metabolites.
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5 Conclusion and future perspectives
The aim of this thesis was to establish a test system to study the protective eﬀect of dietary
ﬁbers and their metabolites against colon cancer by using gene expression analysis. Therefore, a
RT-qPCR method was adapted for gene expression analysis in HT-29 and HCT-116 cells. For the
correct application of this method the experimental setups of all diﬀerent steps had to be optimized.
In conclusion, the following steps were found to be important. A sterile technique during RNA
isolation and the use of DNase proved to be important for obtaining RNA templates preparations
free from RNase or genomic DNA contaminations. The use of correct dilutions and right choice
primers was important for obtaining good quality cDNA. An important consideration for analyzing
the RT-qPCR data was the identiﬁcation of valid reference genes. For this purpose, the application
of the freely available validation programs BestKeeper and NormFinder was of beneﬁt. The target
genes chosen in this thesis were an initial starting point for establishing the test system. They were
chosen because of their roles in inﬂammation (NFκB1 and PTGS2 ) or inhibition of carcinogenesis
(NFE2L2 ). The down-regulation of NFκB1 and PTGS2 and up-regulation of NFE2L2 gene
expression observed in HT-29 cells treated with dispersible wellmune or butyrate may be one
potential mechanism of dietary ﬁber's protective eﬀect against the development of colon cancer.
Based on these results it seems likely that the established test system will be able to give
new insights into the molecular mechanisms of this protective eﬀect and at the same time enable
the selection of dietary ﬁber types or metabolites with the highest protective potential in future
studies. The development of colon cancer is associated with a change in the expression of plenty
of genes. It would be interesting to further study dietary ﬁber types using the established test
system and to apply a DNA microarray analysis to the ﬁber types with the strongest eﬀects. In
this way the expression levels of several thousand genes treated with the speciﬁc dietary ﬁber can
be studied at the same time. If further dietary-ﬁber regulated genes would be found, patterns and
relations between the genes could be analyzed. These patterns may help to understand more of
the molecular mechanisms involved in the protective eﬀects of the respective dietary ﬁber types.
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